demands for grants 2016-17 (demand no. 5) of the (ministry of …164.100.47.5 › newcommittee ›...

Rajya Sabha Secretariat, New Delhi

PARLIAMENT OF INDIA

DEPARTMENT-RELATED PARLIAMENTARY STANDING COMMITTEE

RAJYA SABHA

ON HEALTH AND FAMILY WELFARE

REPORT NO.

95

(Presented to the Rajya Sabha on 29th April, 2016)(Laid on the Table of Lok Sabha on , 2016)29th April

Demands for Grants 2016-17 (Demand No. 5)of the

(Ministry of AYUSH)

NINETY-FIFTH REPORT

April, 2016/Vaisakha, 1938 (Saka)

Website : http://rajyasabha.nic.inE-mail : [email protected]

PARLIAMENT OF INDIARAJYA SABHA

DEPARTMENT-RELATED PARLIAMENTARY STANDING COMMITTEEON HEALTH AND FAMILY WELFARE

NINETY-FIFTH REPORT

Demands for Grants 2016-17 (Demand No. 5)of the

Ministry of AYUSH

(Presented to the Rajya Sabha on the 29th April, 2016)(Laid on the Table of Lok Sabha on the 29th April, 2016)

Rajya Sabha Secretariat, New DelhiApril, 2016/Vaisakha, 1938 (Saka)

Hindi version of this publication is also available

CONTENTS

PAGES

1. COMPOSITION OF THE COMMITTEE ....................................................................................... (i)-(ii)

2. INTRODUCTION ...................................................................................................................... (iii)

3. ACRONYMS ............................................................................................................................ (iv)-(v)

4. REPORT ................................................................................................................................. 1-35

5. OBSERVATIONS/RECOMMENDATIONS—AT A GLANCE ............................................................. 36-43

6. MINUTES ............................................................................................................................... 45-51

7. ANNEXURES........................................................................................................................... 53-71

COMPOSITION OF THE COMMITTEE(2015-16)

1. Prof. Ram Gopal Yadav — Chairman

RAJYA SABHA2. Shri Ranjib Biswal3. Shri Rajkumar Dhoot4. Dr. Bhushan Lal Jangde

+5. Smt. B. Jayashree6. Dr. R. Lakshmanan7. Shrimati Kahkashan Perween8. Shri Ambeth Rajan9. Shri Jairam Ramesh

^10. Dr. T.N. Seema

LOK SABHA11. Shri Thangso Baite12. Dr. Subhash Ramrao Bhamre13. Shrimati Ranjanaben Bhatt14. Shri Nandkumar Singh Chauhan15. Dr. Ratna De (Nag)

#16. Shri Devendra alias Bhole Singh17. Dr. (Smt.) Heena Vijay Gavit18. Dr. Sanjay Jaiswal19. Dr. K. Kamaraj20. Shri Arjunlal Meena21. Shri J. Jayasingh Thiyagaraj Natterjee22. Shri Chirag Paswan23. Shri C. R. Patil24. Shri M.K. Raghavan25. Dr. Manoj Rajoria26. Dr. Shrikant Eknath Shinde27. Shri R.K. Singh28. Shri Kanwar Singh Tanwar

(i)

+ ceased to be member of the Committee w.e.f. 21st March,2016.

^ ceased to be member of the Committee w.e.f. 2nd April, 2016.

# ceased to be member of the Committee w.e.f. 18th April,2016.

(ii)

29. Shrimati Rita Tarai30. Shri Manohar Untwal31. Shri Akshay Yadav

SECRETARIATShri P.P.K. Ramacharyulu, Additional SecretaryShri Anil Kumar Gandhi, DirectorShri Dinesh Singh, Joint DirectorShri Rajesh Kumar Sharma, Assistant DirectorShri Pratap Shenoy, Committee Officer

INTRODUCTION

I, the Chairman of the Department-related Parliamentary Standing Committee on Health and FamilyWelfare, having been authorized by the Committee to present the Report on its behalf, hereby present this95th Report of the Committee on the Demand for Grants (Demand No 05) of the Ministry of AYUSH, for theyear 2016-17.

2. The Committee held one sitting, on 21st March, 2016 for examination of Demands for Grants of theMinistry of AYUSH and heard the Secretary (AYUSH) and other Officers thereon.

3. The Committee considered the Draft Report and adopted the same in its meeting held on 28th April, 2016.

4. The Committee while making its observations/recommendations has mainly relied upon the followingdocuments:–

(i) Address by the President of India to both Houses of Parliament assembled together on 23rd

February, 2016;(ii) Speech of Finance Minister on 28th

February, 2016 while presenting the Union Budget 2016-17;(iii) Implementation of Budget Announcements 2015-16;(iv) Detailed Demands for Grants of the Ministry of AYUSH for the year 2016-17;(v) Annual Report of the Ministry for the year 2015-16;(vi) Outcome Budget of the Ministry for the year 2016-17;(vii) Detailed Explanatory Note on Demands for Grants of the Ministry of AYUSH for the year

2016-17;(viii) Physical and financial targets fixed and achievements made so far during the Twelfth Plan

period;(ix) Projection of outlays for the schemes to be undertaken by the Ministry during the remaining

years of the Twelfth Five Year Plan;(x) Details of under-utilization of the allocations made under different heads during the last three

years;(xi) Written replies furnished by the Ministry to the Questionnaires sent to them by the Secretariat;(xii) Presentation made by the Secretary (AYUSH) and other concerned officers; and(xiii) Written clarifications furnished by the Ministry, on the points/issues raised by the Members

during the deliberations of the Committee.

5. For facility of reference and convenience, observations and recommendations of the Committeehave been printed in bold letters in the body of the Report.

PROF. RAM GOPAL YADAVNEW DELHI; Chairman,April 28, 2016 Department-related Parliamentary StandingVaishakha 8, 1938 (Saka) Committee on Health and Family Welfare

Rajya Sabha.

(iii)

ACRONYMS

AYUSH : Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy

AIIA : All India Institute of Ayurveda

AIIY : All India Institute of Yoga

AIIH : All India Institute of Homoeopathy

AIUM : All India Institute of Unani Medicine

ASUDTAB : Ayurveda, Siddha, Unani Drug Technical Advisory Board

AES : Acute Encephalitis Syndrome

CCIM : Central Council of Indian Medicine

CCH : Central Council of Homoeopathy

CCRAS : Central Council for Research in Ayurvedic Sciences

CCRUM : Central Council for Research in Unani Medicine

CCRH : Central Council for Research in Homoeopathy

CCRYN : Central Council for Research in Yoga and Naturopathy

CCRS : Central Council for Research in Siddha

CDSCO : Central Drug Standard Control Organization

D.Y.Sc. : Diploma in Yogic Science

DCC : Drug Control Cell

EFC : Expenditure Finance Committee

EHIP : Effects of Homoeopathic Intervention in Pre-Diabetes

FEDMAP : Federation of Medicinal and Aromatic Plants Stakeholders

FRLHT : Foundation for Revitalisation of Local Health Traditions

FSMHP : Foundation for Spastic and Mentally Handicapped Persons

HPL : Homoeopathic Pharmacopoeial Laboratory

IPGTRA : Institute of Post Graduate Teaching and Research in Ayurveda

IMPCL : Indian Medicines Pharmaceutical Corporation Ltd.

ISM&H : Indian Systems of Medicines and Homoeopathy

ICFRE : Indian Council for Forest Research and Education

(iv)

ICPO : Institute of Cytology and Preventive Oncology

IEC : Information, Education and Communication

MDNIY : Morarji Desai National Institute of Yoga

MSP : Minimum Support Price

MPs : Medicinal Plants

NIA : National Institute of Ayurveda

NIS : National Institute of Siddha

NIH : National Institute of Homoeopathy

NIUM : National Institute of Unani Medicine

NIN : National Institute of Naturopathy

NEIAH : North Eastern Institute of Ayurveda and Homoeopathy

NEIFM : North Eastern Institute of Folk Medicine

NMPB : National Medicinal Plant Board

NEGERD : Non-Erosive Gastroesophageal Reflux Disease

NIRT : National Institute for Research in Tuberculosis

PCIM : Pharmacopoeia Commission for Indian Medicine

PLIM : Pharmacopoeial Laboratory for Indian Medicine

RAV : Rashtriya Ayurveda Vidyapeeth

RRIUM : Regional Research Institute of Unani Medicine

RCTs : Randomized Controlled Trials

SVDYWC : Swami Vivekananda District Yoga Wellness Centre

SMPBs : State Medicinal Plants Boards

TKDL : Traditional Knowledge of Digital Library

UCs : Utilization Certificates

(v)

1

REPORT

Brief Background

1. The Ministry of AYUSH came into existence w.e.f. 09.11.2014. Previously, it was known as adepartment established in 1995 under the Ministry of Health and Family Welfare and was designated as theDepartment of Indian Systems of Medicine and Homoeopathy (ISM&H). It was further re-designated as theDepartment of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) in November,2003. Formation of the Ministry of AYUSH is an offshoot of the policy of the Government’s thrust onrecognition and significance of the Traditional Systems of Indian Medicine.

1.2 The Ministry is responsible for policy formulation, development and implementation of programmesfor the growth, development and propagation of Ayurveda, Yoga and Naturopathy, Unani, Siddha andHomoeopathy (AYUSH) systems of Health Care. Sowa Rigpa is the recent addition to the existing family ofAYUSH systems.

Composition

1.3. The Ministry has a broad Institutional framework to carry out its activities in the field of AYUSHconsisting of: -

1.4 Regulatory Bodies: -

Central Council of Indian Medicine (CCIM)

Central Council of Homoeopathy (CCH)

1.5 Research Councils

Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi;

Central Council for Research in Unani Medicine (CCRUM), New Delhi;

Central Council for Research in Homoeopathy (CCRH), New Delhi;

Central Council for Research in Yoga and Naturopathy (CCRYN), New Delhi; and

Central Council for Research in Siddha (CCRS), Chennai.

1.6 Educational Institutions

National Institute of Ayurveda (NIA), Jaipur;

National Institute of Homoeopathy (NIH), Kolkata;

National Institute of Naturopathy (NIN), Pune;

National Institute of Unani Medicine (NIUM), Bangalore;

Institute of Post Graduate Teaching and Research in Ayurveda (IPGTRA), Jamnagar (aided bythe Department);

1

2

Morarji Desai National Institute of Yoga (MDNIY), New Delhi;

National Institute of Siddha (NIS), Chennai;

Rashtriya Ayurveda Vidyapeeth (RAV), New Delhi;

All India Institute of Ayurveda, New Delhi (being developed)

North Estern Institute of Ayurveda and Homoeopathy, Shillong (being developed); and

North Eastern Institute of Folk Medicine, Passighat, East Siang District, Arunachal Pradesh(being developed).

1.7 Laboratories & Pharmacopoeia Commission

Pharmacopoeial Laboratory for Indian Medicine (PLIM), Ghaziabad;

Homoeopathic Pharmacopoeial Laboratory (HPL), Ghaziabad; and

Pharmacopoeia Commission for Indian Medicine (PCIM), Ghaziabad.

1.8 Public Sector Undertakings

Indian Medicines Pharmaceutical Corporation Ltd. (IMPCL).

1.9 National Medicinal Plant Board (NMPB).

1.10 Drug Control Cell (AYUSH).

1.11 The National Policy on Indian Systems of Medicine and Homoeopathy (ISM&H) adopted in 2002,paved way for integration of ISM with health delivery systems in an improved and phased manner, whichwas taken forward both by the AYUSH Department and as part of the mainstreaming component of AYUSHunder the National Rural Health Mission (NRHM) resulting into a considerable expansion of AYUSH services.

NATIONAL AYUSH MISSION

1.12 The Union Government of India has approved and notified National AYUSH Mission (NAM) on29.09.2014 after merging the following Centrally Sponsored Schemes: -

(i) Centrally Sponsored Scheme Development of AYUSH Hospitals and Dispensaries;

(ii) Centrally Sponsored Scheme Development of AYUSH Institutions;

(iii) Centrally Sponsored Scheme Development of Quality Control of ASU&H Drugs; and

(iv) National Mission on Medicinal Plants.

1.13 Prior to the launching of NAM, these four Centrally Sponsored Schemes were implementedindividually, which, however, were grouped/merged together under NAM subsequent to Cabinet approval inSeptember, 2014. At the Central level, the Mission is steered by a National AYUSH Mission Directorate,chaired by Secretary (AYUSH) with members from other Departments and assisted by an Appraisal Committeesupported by Central Programme Management Unit (PMU). At the States/UT level, there is a provision fora separate State/UT AYUSH society whose Governing Body is chaired by the Chief Secretary and ExecutiveBody chaired by the Principal Secretary/Secretary in charge of AYUSH to oversee the implementation of theScheme.

3

Objectives of National AYUSH Mission (NAM)

1.14 National AYUSH Mission inter-alia envisages: -

Better access to AYUSH services through increase in number of AYUSH Hospitals andDispensaries

Ensure availability of AYUSH drugs and trained manpower

Improvement in quality of AYUSH education through enhancement in the number of upgradedAYUSH educational Institutions

Improvement in availability of quality ASU&H drugs through increase in number of Pharmacies

Setting up of Drug Laboratories in the States which are responsible for enforcement mechanismof ASU&H drugs

Sustain availability of quality raw materials by promoting Medicinal plants.

1.15 Consequent upon rationalisation of the Central Sector Schemes and Centrally Sponsored Schemes,the total ongoing main umbrella schemes were reduced from 12 to 6 only (five Central Sector and oneCentrally Sponsored) and total schemes and sub-schemes to 46 as mentioned hereunder: -

Central Sector Schemes

A. Strengthening of Ministry of AYUSH

(i) Secretariat – Ministry of AYUSH

B. Support to AYUSH Institutions

(i) All India Institute of Ayurveda (AIIA), New Delhi

(ii) All India Institute of Yoga (AIIY)

(iii) All India Institute of Homoeopathy (AIIH)

(iv) All India Institute of Unani Medicine (AIUM)

(v) Grant for Institute of Post Graduate Teaching and Research in Ayurveda (IPGTRA), Jamnagar

(vi) Grant to National Institute of Ayurveda (NIA), Jaipur

(vii) Grant to Rashtriya Ayurveda Vidyapeeth (RAV)

(viii) Grant to National Institute of Siddha (NIS), Tamil Nadu

(ix) Grant to National Institute of Homoeopathy (NIH), Kolkata

(x) Grant to National Institute of Unani Medicine (NIUM), Bangalore

(xi) Morarji Desai National Institute of Yoga (MDNIY), New Delhi

(xii) Grant to National Institute of Naturopathy (NIN), Pune

(xiii) North Eastern Institute of Ayurveda and Homoeopathy (NEIAH), Shillong

(xiv) North Eastern Institute of Folk Medicine (NEIFM), Passighat, East Siang District, ArunachalPradesh

4

(xv) National Institute of Medicinal Plants

(xvi) National Institute of Sowa Rigpa

(xvii) Indian Institute of AYUSH Pharmaceutical Sciences

(xviii) Public Sector Undertaking – Indian Medicines Pharmaceutical Corporation Limited (IMPCL), U.P.

C. Support to Statutory Institutions

(i) Grant to Central Council of Indian Medicine (CCIM), New Delhi

(ii) Grant to Central Council of Homoeopathy (CCH), New Delhi

(iii) National Medicinal Plant Board (NMPB)

D. Research & Development

(i) Grant to Central Council for Research in Ayurvedic Sciences

(ii) Grant to Central Council for Research in Unani Medicine

(iii) Grant to Central Council for Research in Yoga & Naturopathy

(iv) Grant to Central Council for Research in Homoeopathy

(v) Grant to Central Council for Research in Siddha

(vi) Central Council for Research in Sowa-Rigpa

(vii) Extra Mural Research Projects through Research Institutes etc.

E. Strengthening of AYUSH Delivery System

(i) Pharmacopoeia Committees of ASU and strengthening of Pharmacopoeia Commission of IndianMedicine (PCIM)

(ii) AYUSH expansions in CGHS

(iii) Yoga training for Police Personnel

(iv) Pharmacopoeial Laboratory of Indian Medicine, Ghaziabad

(v) Homoeopathic Pharmacopoeia Laboratory, Ghaziabad

(vi) Information, Education and Communication

(vii) AYUSH and Public Health

(viii) Assistance to accredited AYUSH Centres of Excellence in non-Governmental/private sectorengaged in AYUSH education/drug development & research /clinical research/folk medicineetc.

(ix) Traditional Knowledge of Digital Library (TKDL) and Indian Systems of Medicines andHomoeopathy (ISM&H) Intellectual Property Rights

5

(x) Re-orientation Training Programme of AYUSH Personnel / Continuing Medical Education (ROTP/ CME)

(xi) Development of AYUSH IT Tools, Applications and Network

(xii) Promotion of International Cooperation

(xiii) Development of common facilities for AYUSH industry clusters

(xiv) Incentive to Industry – Participation in fairs/conducting market survey

(xv) Pharmacovigilance initiative for ASU drugs

(xvi) Central Drug Controller for AYUSH

Centrally Sponsored Schemes

F. National Health Mission: AYUSH

(i) National AYUSH Mission (NAM)

2. Budgetary Allocation

2.1 As per the information furnished to the Committee, during the Eleventh Five Year Plan, the Ministryof AYUSH (erstwhile Department of AYUSH) was initially allocated 3988.00 crore for the plan schemes.Against this actual year-wise plan allocation (B.E.) received during Eleventh Five Year Plan was 3456.00crore. The total expenditure during Eleventh Five Year Plan was 2993.83 crore. The plan allocation andexpenditure during the last four years of the Twelfth Plan is as under :-

Table No. 1

(` in Crore)

Year Allocation Utilisation of Funds

BE RE

2012-13 990.00 670.00 580.60

2013-14 1069.00 750.00 553.50

2014-15 1069.00 466.78 463.13

2015-16 1008.00 900.00 *886.82

* Expenditure upto 31.03.2016.

2.2 Apprising the Committee of the total RE allocations made in the first four years of the 12th Planvis-à-vis, the total Twelfth Plan approved outlays and the actual expenditure incurred, the Ministry hasstated that against the total approved outlay of 10044.00 crore, the total allocation made in RE from2012-13 to 2015-16 is 2786.78 crore and the actual expenditure is 2362.93 crore (expenditurefigures as on 29th February, 2016). Scheme/ programme-wise expenditure during 2012-13 to 2015-16 isgiven in Annexure-I.

2.3 The Twelfth Plan total approved outlays, total BE, RE and AE during the last four years and planallocation for the financial year 2016-17 as informed by the Ministry of AYUSH is as under: -

6

Table No. 2

(` in Crore)

12th

Plan Outlay BE RE Actual Expenditure Plan Allocation2012-13 2012-13 2012-13 For the Financial

To To To Year 2016-172015-16 2015-16 2015-16

(upto29.02.16)

10044.00 4136.00 2786.78 2362.93 1050.00

2.4 For the year 2016-17, the Ministry of AYUSH has been allocated an amount of 1050.00 croreunder the Plan Head. The Ministry has informed that the allocation of 1050.00 crore has been madeagainst the projected demand of 1819.77 crore.

2.5 Apprising the Committee of the expenditure vis-a-vis allocations made on the Plan side under variousmajor schemes/programmes for 2015-16 the Ministry has furnished the following information:-

Table No. 3Plan Allocation and Expenditure for 2015-16 under major schemes/programmes

(` in Crore)

Sl. Schemes/Programmes BE RE AE Excess(+) /No. (As on Savings (-)

29.02.16)

1. Central Sector Schemes System Strengthening 165.00 117.91 112.93 -52.07

(a) Strengthening of Department of AYUSH 37.20 19.00 18.60 -18.60

(b) Statutory Institutions 1.45 1.55 1.55 0.10

(c) Hospitals and Dispensaries 94.35 58.79 58.14 -36.21

(d) Strengthening of Pharmacopeial Laboratories 8.00 5.57 4.46 -3.54

(e) Information, Education and Communication 20.00 30.00 27.23 7.23

(f) AYUSH and Public Health 4.00 3.00 2.95 -1.05

2. Educational Institutions 200.00 145.27 138.59 -61.41

3. Research and Development including Medicinal Plants 300.00 286.43 286.21 -13.79

(1) Research Councils 231.00 229.03 229.16 -1.84

(2) National Medicinal Plants Board 69.00 57.40 57.05 -11.95

4. HRD (Training Programme/Fellowship/Exposure Visit 2.00 2.00 2.00 0.00

5. Development of AYUSH Industry 11.10 9.25 8.91 -2.19

6. Pharmacovigilance initiative for ASU drugs 1.00 0.00 0.00 -0.10

7

7. National AYUSH Library and Archives 0.10 0.00 0.00 -0.10

8. Central Drug Controller for AYUSH 1.00 0.00 0.00 -1.00

B. Centrally Sponsored Scheme

(i) National Mission on AYUSH including 318.00 331.14 331.01 -13.01Medicinal Plants

TOTAL 1008.00 900.00 886.82 -121.18

2.6 Apprising the Committee of the financial performance of the Ministry during 2015-16, theSecretary, Ministry of AYUSH during his evidence before the Committee on 21

st March, 2016 submitted

that 2015-16 was the first full year of the National AYUSH Mission and the Ministry has achievedalmost hundred percent utilization of the budgetary funds. He also submitted that it was slightlyunfortunate that despite the fact that the Ministry had achieved more than its target of utilization offunds by September (2015) end, the Ministry had to suffer a Budget cut of hundred crores in the totalBE 2015-16 allocation.

2.7 In reply to a query, the Secretary (AYUSH) informed that the Ministry has been allocated 1050.00 crore on the plan side for 2016-17 as against the projected demand of 1819.77 crore.

2.8 On being asked about the effect of the reduced allocation for 2016-17 on the activities of theMinistry, the Secretary informed the Committee that the goals of the National AYUSH Mission would beadversely affected.

2.9 In reply to another query regarding the share of central expenditure on AYUSH in the total expenditureon AYUSH in the country, he submitted that most of the States are largely implementing the Central-sectorschemes. Since the Centre-States funding pattern is 60:40, it means that “if we are spending 60 per cent, theStates are spending the balance 40 per cent. But there are many States which, on their own, have a verylarge AYUSH budget, especially in South India.”

2.10 The Committee has also been furnished the following information regarding the quantum of expenditurein percentage terms in each quarter of the fiscal year 2015-16:----

Table No. 4

BE RE Percentage Expenditure w.r.t. BE(upto 21.3.16)

Ist Qtr. IInd Qtr. IIIrd Qtr. IVth Qtr.

Plan 1008.00 900.00 25.69 35.00 8.59 13.23

Non-Plan 206.00 225.00 25.53 38.83 15.74 27.66

2.11 From the information provided by the Ministry, the Committee finds that there were certain budgetaryheads under which the entire budgeted plan funds had to be surrendered in 2015-16. These budgetary headsare as under:----

8

Table No. 5

(` in crore)

Sl. Name of the Scheme BE 2015-16 Reason for surrenderNo.

1 All India Institute of Yoga 0.10 Non-approval of the scheme

2 All India Institute of Unani Medicine 15.00 Non-approval of the scheme

3 Homoeopathic Medicines Pharmaceutical 0.10 Non-approval of the schemeCo. Ltd.

4 Acquisition of Office Building 11.50 Payment to NBCC discontinued on thedirection of the Ministry of Finance

5 National Institute of Medicinal Plants 0.50 Non-approval of the scheme

6 Indian Institute of AYUSH Pharmaceutical 0.10 Non-approval of the schemeSciences

7 TKDL and ISM&H Intellectual Property 0.10 Non-receipt of any proposals fromRights TKDL

8 Survey on usage and acceptability of AYUSH 0.20 No proposal received to conductsurvey/evaluation

9 Central Council for Research in Sowa Rigpa 0.50 Non-approval of the scheme

10 Scheme for Acquisition, Cataloguing, 0.50 Scheme discontinuedDigitisation and Publication of Text Booksand Manuscripts

11 Development of AYUSH IT Tools, 0.30 As per actual requirementApplications and Networks

12 Pharmacovigilance initiative for ASU drugs 1.00 Non-approval of the scheme

13 National AYUSH Library and Archives 0.10 Non-approval of the scheme

14 Central Drug Controller for AYUSH 1.00 Non-approval of the scheme

2.12 In reply to a question regarding the expenditure incurred during 2015-16 under the Central Sectorand Centrally Sponsored Schemes, the Ministry has furnished the following information:----

Table No-6

(` in crore)

Scheme BE Expenditure % utilisation RE Expenditure (as on as on 30.09.15 29.2.2016)

Centrally Sector 690.00 338.01 48.99 568.86 480.61Scheme

Centrally Sponsored 318.00 273.76 86.09 331.14 300.30Scheme

TOTAL 1008.00 611.77 60.69 900.00 780.91

9

2.13 The Ministry has also furnished information regarding expenditure figures vis-à-vis the BE and REallocations scheme/programme-wise for 2014-15 and 2015-16 which is at Annexure-II.

2.14 The following information has been supplied to the Committee regarding percentage of surrenderedfunds on account of normal savings, economy measures and non-approval of schemes/programmes during2014-15 and 2015-16-:

Table No. 7

(` in crore)

Total Amount Normal savings On account of On account of Non-approval ofsurrendered economy measures Schemes/ inadequate proposals

2014-15

573.20 0.30% 0.00% 99.70%

2015-16

89.06 1.17% 0.00% 98.83%

2.15 The Ministry has cited the following reasons for under-utilization of the budgeted funds for variousschemes: -

(i) Non-filling of vacant posts;

(ii) Non-approval of the Schemes;

(iii) Increase / reduction in allocation at RE stage;

(iv) Unspent balance;

(v) Pending Utilisation Certificates;

(vi) Delay in execution of work;

(vii) Non-receipt of adequate and viable proposals; and

(viii) Tardy/delayed pace of construction and procurement, etc.

2.16 The Ministry has also informed the Committee that it has taken the following steps for ensuringoptimum utilization of funds during 2015-16:----

(i) Regular periodic expenditure review meetings were held at Secretary and Joint Secretary levelto scrutinize the status of utilization of budgetary allocations under various heads and also todraw periodic roadmap for course correction and improved uptake of funds. Projections ofexpenditure on month / quarter-wise was made and vigorously implemented.

(ii) As a result of constant dynamic assessment of monitoring, the utilization of funds that wasput in place, possible slack in certain Schemes were identified in a timely manner so thatavailable funds could be utilized in other areas where it was required. Consequently savings tothe tune of ` 119.89 crore were identified by regular monitoring under various heads and re-appropriated where demand existed through seeking approval under supplementary grants.

10

The details of the approval sought by identifying available savings through the three batches ofsupplementary grants as given below :

1st Batch. ` 44.59 crore (Plan)

2nd Batch ` 19.75 crore (Plan)

3rd Batch ` 55.55 crore (Plan + Non-Plan)

(iii) Special emphasis was laid in ensuring timely flow of funds during the first two quarters of theFinancial Year 2015-16.

(iv) Special focus was given to expenditure in priority areas viz. SCSP, TSP and North Easternregion, to avoid any slack.

(v) Consequent to the adoption of these measures, pace of expenditure and utilization wassignificantly high in 2015-16 than previous years. In fact, the Ministry has made a turnaroundin utilization of funds.

(vi) For Centrally Sponsored Scheme of National AYUSH Mission:-

(a) All State / UT Governments were requested to furnish the State Annual Action Plan forrequirement of funds as per resource pool under NAM.

(b) The State Chief Secretaries were also requested to give their personal attention to drawthe entire amount released under the Mission from the state treasury and utilize the Grant-in-aid.

(c) The Ministry has reviewed the progress of implementation for the past release from theState/UTs during the Mission Directorate meetings.

(d) All State / UT Governments were requested to furnish the utilization certificates for erstwhileCentrally Sponsored Scheme.

2.17 For all new integrated AYUSH Hospitals approved by the Ministry, the States were asked by theMinistry to sanction the required permanent posts within one year.

2.18 The Committee observes from Table No. 2 that as against the total Twelfth Plan approvedoutlays of `̀̀̀̀ 10044.00 crore, the total allocation made in RE from 2012-13 to 2015-16 is `̀̀̀̀ 2786.78crore and the expenditure incurred as on 29th February, 2016 is `̀̀̀̀ 2362.93 crore only. The Committeenotes from Table 1 that the actual expenditure has invariably been considerably lower than theRevised Estimates in 2012-13 and 2013-14 and slightly lower in 2014-15. Despite the fact that a ZeroBased Budgeting exercise which requires that budget request be evaluated thoroughly, startingfrom the zero base, was undertaken at the beginning of the Eleventh Plan, a substantial amount of`̀̀̀̀ 423.85 crore of the budgeted funds could not be utilised during the first four years of the TwelfthPlan period, which is a matter of serious concern. The Committee is constrained to observe thatsuch a substantial gap between the RE allocations and the actual expenditure is indicative of fiscalindiscipline and unrealistic projection of estimates. Had the Ministry assessed requirement of fundsrealistically and monitored their deployment diligently such a shortfall in utilization of the budgetedfunds could have been avoided and the unspent amount utilized more gainfully somewhere else.The Committee, therefore, recommends that a comprehensive analysis of the trend of expenditure

11

incurred under various heads of the Ministry during the last four years be carried out with a view torectifying and improving upon the existing system of assessing fund requirement. The Committeewould also expect the Ministry to make its estimates only after proper assessment and planning infuture.

2.19 The Committee notes that the Ministry has been allocated `̀̀̀̀ 1050.00 crore in BE 2016-17on the plan side against the projected demand of `̀̀̀̀ 1819.77 crore and thus there is a shortfall of`̀̀̀̀ 769.77 crore. The Committee takes note of the submission of the Secretary (AYUSH) that “wewill be able to achieve almost hundred percent utilization” of the funds budgeted for 2015-16 andthat the goals of the National AYUSH Mission will be affected due to the shortfall in allocation for2016-17. The Committee observes that health needs of a vast and diverse country like India cannotbe met by a single healthcare system and AYUSH healthcare systems, which besides being curative,are also preventive and promotive healthcare systems, have a vital role to play in expanding theoutreach of healthcare to the people because of their inherent advantages in terms of diversity,modest cost, low level of technological input, etc. The shortfall in allocation for 2016-17 will haveadverse impact on the key priorities of the National AYUSH Mission which aims at mainstreamingof AYUSH, improving quality of ASU&H drugs, setting up of drug laboratories, improvement inAYUSH education etc. The Committee observes that the BE 2016-17 allocation of `̀̀̀̀ 1050.00 crore islower than the BE 2013-14 and 2014-15 allocation of `̀̀̀̀ 1069.00 crore each and is only marginallyhigher than the allocation of `̀̀̀̀ 1008.00 crore in BE 2015-16. The Committee observes that in aresource-constrained country like India, it is extremely difficult to meet the demands for funds,however genuine, of the Ministry in full and therefore in order to obtain the best possible healthoutcomes, it is imperative that allocation of resources is prioritized across competing ends. TheCommittee would, therefore, like the Ministry to work out the bare minimum additional increasethat the Ministry needs in its budget for 2016-17 for carrying out activities/ programmes which areabsolutely essential and cannot be postponed till next year and approach the Ministry of Finance forallocating that amount through supplementary grants. The Committee desires to be kept apprisedof the response of Ministry of Finance in this regard.

2.20 The Committee notes that as compared to the BE 2016-17 allocation of `̀̀̀̀ 31300.00 crore forthe Department of Health and Family Welfare, the Central expenditure on AYUSH for 2016-17 is`̀̀̀̀ 1050.00 crore only. State Governments are spending much more on AYUSH than the UnionGovernment. To make an in-depth analysis of total Government expenditure on AYUSH, theCommittee would like the Ministry to collect and furnish information to the Committee on thetotal Government expenditure on AYUSH (i.e. combined spending on AYUSH by the Centre and allStates) as also the Centre-States ratio in total Government expenditure on AYUSH. The Committeewould also like to know whether any policy pronouncement of raising AYUSH share in totalGovernment expenditure on health had been articulated in the Twelfth Five Year Plan.

2.21 The Committee’s scrutiny of Table No. 5 reveals that for 14 heads of account, budgetaryprovisions had been obtained in BE 2015-16 but not a single rupee was spent. Of the 14 schemes, thebudgeted funds of as many as nine schemes could not be utilised due to non-approval of the schemes.For example, `̀̀̀̀ 15.00 crore had been allocated at the stage of BE 2015-16 for “All India Institute ofUnani Medicine” but nothing was spent and the entire allocated amount of `̀̀̀̀ 15.00 crore wassurrendered. The Committee is of the considered view that this trend is indicative of seriousshortcomings in formulating the Budget Estimates and ineffective monitoring of utilization of the

12

budgeted funds for implementing schemes. The Committee, therefore, recommends to the Ministryto take appropriate corrective measures to arrest this trend of inappropriate projection of fundrequirements in formulating budget estimates for schemes, which are left unutilised owing to lackof approvals, non-receipt of proposals etc. The Committee would advise the Ministry to proposebudget allocations for schemes only after obtaining all necessary clearances so that the scarceresources do not remain locked up and surrendered later.

2.22 The Committee observes from Table No.4 that the Ministry incurred expenditure of `̀̀̀̀ 38.83crore of the non-plan funds in the second quarter of the Financial Year 2015-16 and has thus breachedthe ceiling of 33% as stipulated by the Ministry of Finance. The Committee would expect the Ministryto show greater financial discipline and responsibility by evenly laying out expenditure in future.

Pending Utilisation Certificates

2.23 The Committee has been monitoring the pendency of Utilization Certificates (UCs) under variousschemes of the Ministry for the last few years. On being asked about the total number of UCs, the amountinvolved therein and the time since when the UCs have been pending, the Ministry has informed that thereare 1529 number of Pending UCs and total amount involved is ` 142.39 crores in Central Sector Schemesfrom 2004-05 to 2013-14. For Centrally Sponsored Schemes, the number of Pending UCs is 309 and totalamount is ` 376.89 crores.

2.24 The Committee is concerned to note that the number of the pending UCs and the amountinvolved therein is still very high despite the efforts made by the Ministry. It is also a matter ofgreat concern that the pending UCs date as far back as 2004-05 which points to the fact that thesteps taken by the Ministry so far have not yielded the desired results. The Committee observesthat the time lag in submission of UCs delays release of funds to the implementing agencies andthus adversely affects quality of spending. It is, therefore, imperative on the part of the Ministry tohave a relook at the system of monitoring of the progress of utilization of the funds at the level ofimplementing agencies and come out with a multi-pronged strategy for liquidation of pending UCsso as to ensure that execution of projects is not delayed due to pending UCs.

3. Updation of Central Registers of Indian Medicine and Homoeopathy

3.1 The updation of Central Registers of Indian Medicine and Homoeopathy has been engaging theattention of the Committee for quite some time. On being asked about the issue of the status of updation ofCentral Registers of Indian Medicines and Homoeopathy, reduction of time lag between the receipt ofinformation from the State Governments and its updation in the Central Registers of Indian Medicine andHomoeopathy, and the forward movement, if any, made towards digitization of Central Registers of IndianMedicine and Homoeopathy, the Ministry in its written reply has informed the Committee that CCIM hasalready started the digitization of Central Register since 10th July, 2015 due to which the time period to obtainCentral Registration Certificate was reduced to 45-60 days (subject to the availability of the name of thepractitioner in the Central Register).

3.2 The Ministry has further informed that the updated status of Central register of Indian Medicine ason 29.01.2016 was that Central Registration of 13 States (Bihar, Chhattisgarh, Goa, Gujarat, Haryana,Himachal Pradesh, Jharkhand, Madhya Pradesh, Orissa, Punjab, Rajasthan, Uttar Pradesh and Uttarakhand)had been completed upto 31.03.2015. The updation of Register for the remaining States was under activeprocess which would further take 3-4 months.

13

3.3 The Ministry has also mentioned that in compliance to advice given by the Committee, CCH hadawarded the contract to a company to undertake the work of digitization of Central Register of Homoeopathywhich would complete the work within next few months. The updation of Central Register of Homoeopathyfor Bihar had been completed upto October, 2015 and also for the States of Andhra Pradesh, ArunachalPradesh, Chhattisgarh, Delhi, Goa, Haryana, Himachal Pradesh, Punjab & Uttarakhand had been completedand was under publication.

3.4 The Central Register in respect of names of practitioners borne on State Registers of Karnataka andAndhra Pradesh would be completed by the end of March, 2016. The time period for updation of the CentralRegister was 3 to 9 month in CCH. The time period was expected to be reduced substantially after digitization.

3.5 The Committee has been impressing upon the Ministry the need for timely updation ofCentral Registers of Indian Medicine and Homoeopathy. The Committee notes that the Ministryhas undertaken the work of digitization of the Central Registers. The Committee observes that theupdation of both Central Registers of the Indian Medicine and Homoeopathy is of vital importancefor HR planning and forecasting. The Committee, therefore, recommends to expedite the workrelating to updation and digitization of both the Central Registers. The Committee also desires tobe apprised of the progress made in this regard.

4. National Institutes

National Institute of Ayurveda (NIA), Jaipur

4.1. In reply to a query regarding the physical and financial performance of NIA during 2015-16, theMinistry has furnished the following information:-

(i) 90 Admissions were made in BAMS Under Graduate Course.

(ii) 83 Admissions were made in M.D./M.S.(Ayurveda) Post-Graduate course.

(iii) 30 Admissions were made in AYUSH Nursing & Pharmacy Diploma Course.

(iv) 47 Mobile Camps have been organized under SCP &TSP in which 52,262 patients wereprovided with free consultation, check-up and medicines.

(v) 197929 patients were treated in OPD.

(vi) 62523 patients treated in IPD.

(vii) The financial performance is as given below:

Table No. 8

(` in crore)

BE RE Expenditure (upto 29.2.2016)

Plan 24.00 18.88 18.21

4.2 Regarding the projected requirement of funds, under plan for NIA for 2016-17 and the actual allocationmade for 2015-16 and the financial performance for 2015-16, the Ministry in a written reply has informedthat for the year 2015-16, the allocation made for NIA, Jaipur under BE was ` 24.00 crore, which was

14

reduced to ` 18.88 crore at RE stage because of reduced allocation of the Ministry at RE stage. The REallocation had been fully utilized. However, further augmentation of ` 1.78 crore had been made at FinalEstimate stage as per requirement.

4.3 In reply to a question regarding the updated status of the sanctioned strength and vacancy positionin NIA, the Ministry has furnished the following information:-

Table No. 9Status of Vacancies (As on 29.02.2016)

Name of Sanctioned Filled Filled on Action taken to fill upPost Strength Regular Contractual Vacant

Basis

Director 1 — — 1 The post of Director, NIA is lying vacantsince 01.06.2014. To fill up the post ofDirector, NIA advertised in the EmploymentNews on 8-14 February, 2014 and re-advertised in the Employment News 21-27February, 2015, total 31 applications havebeen received against both theadvertisements. The scrutiny committee hasbeen constituted on 29.02.2016, forscrutiny of applications. The post ofDirector, NIA is likely to be filled withinnext 3-4 months.

Professor 14 4 6 4 During the year 2013, 5 Posts of ProfessorsAssociate 29 17 4 8 and 5 Posts of Associate Professors wereProf. filled by Retired Teachers on contractualAssistant 52 41 — 11 basis. During the year 2014, 4 Posts ofProf & Professors and 3 Posts of AssociateLecturer Professors were filled by Retired Teachers

on contractual basis. During the year 2015,4 Posts of Professors and 2 Posts ofAssociate Professors were filled by RetiredTeachers on contractual basis. During thecurrent year 2016, 6 posts of Professorsand 4 Posts of Associate Professors standfilled by Retired Teachers on contractualbasis against the vacancies.

TOTAL 95 62 10 23

4.4 The Committee has been reviewing the vacancy position at NIA, Jaipur and urging theMinistry to fill them up within a short span of time. The Committee is, therefore, deeply concernedto note that out of 95 Group ‘A’ posts, as many as 23 are vacant. The Committee observes that sucha large number of vacancies in Group ‘A’ posts will certainly lead to compromise in its mandatedactivities and affect the quality of teaching and research at NIA. The Committee would, therefore,

15

reiterate its recommendation made in its 84th Report that the Ministry may explore the possibilityof appropriately revising the methods and conditions of recruitment of senior faculty withoutcompromising the requisite standards.

5. National Institute of Homoeopathy (NIH), Kolkata

5.1 National Institute of Homoeopathy (NIH) was established on 10th December, 1975 in Kolkata as anautonomous institution under the Ministry of AYUSH and imparts education in Homoeopathy serving as amodel institution for other schools across the country. The brief information pertaining to achievements ofNIH during 2015-16 as furnished by the Ministry as under:----

Academic Activities

5.2 On the issue of finalization of amendment to the Recruitment Rules concerning senior faculty, theMinistry in a written reply has submitted that the draft Recruitment Rules had been received from NIH andcomments of Teachers Welfare Association on the draft Recruitment Rules (RRs) had also been received on02.03.2016, which are being processed for seeking approval of competent authority.

5.3 Regarding the vacant posts in National Institute of Homoeopathy, the Committee was informed thatthese will be filled up in the next 3-4 months. However, the vacant posts had been filled up on contractual/outsourcing basis.

5.4 Taking into account that a number of vacancies in teaching cadre had been persistingsince long, the Committee in its 84th Report on Demand for Grants (2015-16) of the Ministry hadrecommended to amend the Rules relating to recruitment, service conditions and quantum ofemoluments of Group ‘A’ posts at NIH so that it would attract talent towards this profession andfacilitate filling of posts. Almost a year has elapsed since then, but the Recruitment Rules (RRs)are still under finalization. The Committee observes that NIH not only imparts education inHomoeopathy, but also serves as a model for other institutes/colleges across the country andtherefore filling of vacant faculty posts at the earliest is of vital importance. The Committee,therefore, recommends that the finalization of amendments to RRs may be completed in a timebound manner. The Committee also desires to be apprised of the updated vacancy position of thefaculty at NIH.

5.5 About the updated status of expansion of NIH, the Ministry in its reply has mentioned that the workof Hospital extension building had already been completed and taken over. Construction of Academic-cum-Library is complete and taken over. Eight departments had been shifted to new building.

5.6 In reply to a question regarding the updated status of implementation/development of Hospitalat NIH and the time-line for completion thereof, the Ministry informed that for 2nd and 3rd phase ofthe project, major works had been completed and the project was expected to be completed by May2016.

5.7 The expansion of the Hospital at NIH from 100 to 250 bed has been engaging the attentionof the Committee and has been commented upon in its various reports on Demands for Grants ofthe Ministry. The Committee observes that the expansion of the Hospital at NIH was targeted tobe completed during 2010-11. During the examination of Demands for Grants (2013-14), theMinistry had informed the Committee that the original cost of `̀̀̀̀ 11.59 crore had been revisedupward to `̀̀̀̀ 13.08 crore and that the project of the expansion of the Hospital Building was likely to

16

be completed by May, 2015. The Committee is, therefore, astonished to note the submission of theMinistry that “major works had been completed and the project was expected to be completed byMay, 2016.” The Committee would, therefore, like the Ministry to explain as to why the projectcould not be completed by May, 2015 and whether the further delay of one year has entailed any costescalation of the Project.

5.8 Regarding the research activities being undertaken at NIH, the Ministry has informed that theresearch and academic activities on Osteoarthritis, Thyroid disorders and Cancer are being undertaken.On being asked about the outcome of clinical research conducted on Thyroid Diseases, Psoriasis andSpondylitis as conducted by Research Wing of NIH, it was informed that at present research was beingcarried out on two aspects i.e. Thyroid Dysfunction and Spondylitis which were ongoing single blindclinical studies with emphasis on livelihood ratio of the participants. Till 31st March 2015, total 1292participants had been screened in thyroid dysfunction – out of which 148 participants showed markedimprovement, 222 participants showed moderate improvement and 408 participants showed mildimprovement. In Psoriasis, out of 250 participants, 30 participants showed marked improvement, 40participants showed moderate improvement and 75 participants showed mild improvement. All theparticipants were being followed up in protocol.

5.9 The Committee notes that the research activities on Osteoarthritis, Thyroid disorders andCancer are being undertaken at NIH. The Committee observes that research projects often witnessappreciable time-lag in translating research leads and outcomes into tangible health products. TheCommittee, therefore, recommends that the Ministry should ensure that the above research projectsare taken to their logical conclusion within the shortest possible span of time and the productsgenerated out of the research projects reach our healthcare system and are used by the people.

6. All India Institute of Homoeopathy (AIIH)

6.1 A provision of ` 38.25 crore had been made for All India Institute of Homoeopathy for BE 2015-16which was raised to ` 50.35 crore at RE stage. On being asked about the reasons for this sharp increase inthe allocation at RE 2015-16 stage, details of progress made towards implementation of the project includingits original cost, the Ministry has informed that the sharp increase in allocation at RE stage in 2015-16 wasfor the purchase of land for AIIH. The Committee’s scrutiny of Demand No. 5 of the Ministry for the year2016-17 reveals that no allocation has been made for AIIH for 2016-17. The Ministry has also informed thatthe possession of land was yet to be taken from DDA and the preliminary cost estimates for the AIIH wasbetween ` 300-350 crore excluding the cost of the land. The Expenditure Finance Committee (EFC) Memowas under process. The next step after EFC approval was selection of Project Management Consultant andpreparation of Detailed Project Report (DPR). Thereafter, matter will be placed before the Cabinet byAugust 2016.

6.2 The Committee notes that the preliminary cost estimates for the AIIH was between`̀̀̀̀ 300-350 crore excluding the cost of the land and observes that it has been seen that the infrastructureprojects often experience time and cost overruns. The Committee would, therefore, like the Ministryto ensure that the implementation of AIIH may be monitored closely at a sufficiently higher levelin the Ministry and ensure that there is no tardiness in implementation of the Project and theresultant cost escalation. The Committee also recommends that all pre-project formalities may becompleted within a set time-frame before making budgetary provisions for the AIIH.

17

7. Morarji Desai National Institute of Yoga (MDNIY), New Delhi

7.1 Morarji Desai National Institute of Yoga (MDNIY) is an autonomous Organisation under the Ministryof AYUSH and a focal Institute for Planning, Training, Promotion and coordination of Yoga Education,Training, Therapy and Research in all its aspects.

7.2 The Ministry of AYUSH during a power-point presentation before the Committee has listed out thefollowing achievements in respect of the Institute: -

1st International Day of Yoga celebrated on 21st June, 2015, with two Guinness World Recordsinvolving 35,985 participants and Maximum number of Nationalities (84) in a single yoga event;

An International Conference on Yoga for Holistic Health organised at Vigyan Bhawan;

A new Central Sector Scheme titled as “Yoga Training for Police Personnel” has been launched;and

Quality Council of India at the behest of Ministry of AYUSH has developed a Scheme forVoluntary Certification of Yoga Professionals.

7.3 The Ministry through a written submission has furnished the following information to the Committeeregarding the financial performance of MDNIY for 2015-16: -

Table No. 10

(` in crore)

BE RE Expenditure(upto 29.2.2016)

Plan 12.00 3.50 1.18

Non-Plan 4.20 4.20 3.08

7.4 On being asked about the reasons for less utilisation of allocated funds, the Ministry has made thefollowing written submission:

7.5 The provision for BE 2015-16 was made for ` 12.00 crore on account of recruitment of facultiesfor B.Sc. degree Course in Yoga Science, diploma in Yoga Science and other educational courses and forcreation of infrastructure for B.Sc. Degree course, certain major works like covering of Amphitheatre area,setting up Laboratories and for Release of Grant-in-aid to Swami Vivekananda District Yoga Wellness Centre(SVDYWC).

7.6 However, under Phase II only 32 centres under SVDYWC are being continued. Posts of Facultieshave been recently created with the approval of Department of Expenditure. Recruitment of faculties forB.Sc (Yoga Science) could not be materialized. This has resulted the reduction at RE stage to ` 3.50crore.

7.7 Out of RE 3.50 Crore an amount of ` 1.18 crore has been utilized and further utilization of ` 2.32crore along with other committed expenditure are under process and will be utilized during the currentfinancial year.

18

7.8 The Committee notes that the allocation of `̀̀̀̀ 12.00 crore made for MDNIY on the plan sideat the stage of BE 2015-16 was reduced to `̀̀̀̀ 1.18 crore at the RE stage. The sum of `̀̀̀̀ 12.00 crore wasearmarked for carrying out very important activities like setting up of laboratories, covering ofamphitheatre, recruitment of faculties for B.Sc. degree courses in Yoga Science etc. which havesignificant bearing on improving the teaching of Yoga. It is, therefore, a matter of anguish for theCommittee that substantial variations have occurred between the sanctioned provisions and theactual expenditure and a substantial amount of funds remained locked up due to the inefficienciesin the planning process. The Committee, therefore, recommends that the Ministry should takecredible action to overcome the deficiencies in the planning process and ensure that the blockage offunds and their subsequent surrender do not recur.

7.9 The Committee has been informed that the allocation of fund for MDNIY under Plan and non-Planfor 2016-17 is ` 4.00 crore and ` 4.50 crore respectively and these funds would be utilised for the followingpurposes:----

(A) Yoga Education programmes:

1. B. Sc(Yoga Science) with intake capacity of 60 students per year

2. Diploma in Yogic Science (D.Y.Sc.) for Graduates of One Year duration.

3. Certificate course in Yoga Science for target Group (para Militry personnel)

(B) Yoga Training Programmes:

1. Certificate course in Yogasana and Certificate course in Pranayama and meditation for HealthPromotion.

2. Foundation course in Yoga Science for wellness of moths duration.

3. Yoga and Health promotion programmes of One Hour each programme for general public

4. Yoga Workshops etc.

(C) Preventive Health care Units of Yoga in CGHS dispensaries.

(D) Yoga Therapy Centers in AYUSH/Allopathic Hospitals.

(E) National Yoga Week

(F) Participation in Aarogya Melas.

(G) International Day of Yoga etc.

(H) SVDYWC scheme

7.10 The Committee observes that among the quantifiable deliverables for 2016-17 are openingof Yoga Therapy Centres in AYUSH/ Allopathic Hospitals and preventive Healthcare units of Yoga inCGHS dispensaries. The Committee desires to be kept apprised of the achievements made vis-à-vistargets sets under these programmes.

8. Regulation of Naturopathy and Yoga

8.1 During the course of examination of Demands for Grants (2015-16), in reply to a query, the Committee

19

had been informed that presently there was no provision for registration of Naturopathy & Yoga practitionersat Central Government level. However, some of the State Governments like Andhra Pradesh, Karnataka,Tamil Nadu, Chhattisgarh, Madhya Pradesh, Rajasthan and West Bengal have provision for registration ofsuch practitioners for BNYS graduates. The Central Government had issued guidelines in the year 2006. In2014 again, the Ministry had circulated a concept note on this subject to all the State Governments, Universitiesand Colleges, and other stake holders. Based on the feedback received in response thereto, the shape andstructure of future mechanism for registration is under deliberation. The then Department of AYUSH haddecided in 2006, not to regulate Yoga and Naturopathy at Central level on the basis of the followingconsiderations:

(a) The CCIM did not agree to the proposed inclusion of Yoga and Naturopathy in their mandateon the plea that it had nothing common with other systems namely Ayurveda, Siddha andUnani.

(b) Setting up of separate Central Council for Yoga and Naturopathy was not agreed to on thegrounds that there were only few practitioners in the field of Yoga and Naturopathy and limitedinfrastructure, which does not justify a separate Regulatory Body.

The Committee had also been informed that the issue of regulation of yoga and Naturopathy wasunder consideration.

8.2 The Committee observes that Yoga is being practised as part of healthy lifestyle and ispopular world-wide. The therapeutic potentials of yoga in the treatment of many life-style relatedor psychosomatic disorders have been demonstrated in several studies. Similarly, Naturopathy hasgreat health promotive and restorative potential. The Committee feels that at a time when yogacentres and naturopathy clinics are mushrooming, standardization of yogic practices and naturopathictreatments and their regulation are of vital importance. The Committee, therefore, desires to bekept apprised as to what was the outcome of the proposal for regulation of Yoga and Naturopathy.

9. North Eastern Institute of Ayurveda and Homoeopathy (NEIAH), Shillong

9.1 The Union Cabinet, in its meeting held on 27th March, 2008, accorded approval for establishment ofthe North Eastern Institute of Ayurveda and Homoeopathy at Shillong to provide health care to the people ofNE Region and Sikkim under Ayurveda and Homoeopathy Systems of Medicine. The Institute is to have 17Ayurvedic and Homoeopathic colleges with the admission capacity of 50 students each along with a 100 bedAyurvedic Hospital and a 50 bed Homoeopathic Hospital comprising Documentation-cum-R&D Centre andPharmacy with Drug Testing Laboratory.

9.2 During the examination of Demands for Grants (2015-16) of the Ministry, the Committee had beeninformed that the Project was originally targeted to be completed during 2011-12. However, due to delay inexecution of the civil work, October 2013 was fixed as the revised timeline for completion of civil work. Thecompletion of civil work had been further delayed and the project was likely to be fully operationalised in 2015.

9.3 Apprising the Committee of the updated status of full operationalization of NEIAH, the Ministry hasnow furnished the following information:-

(i) Procurement of Furniture: Furniture for faculty & class rooms supplied. Supply of furniturefor Hospital is in process.

20

(ii) Procurement of Equipment:

All essential equipments have been procured.

(iii) Establishment of Library:

Tender have been invited for empanelment of Supplier/Publishers for procurement of LibraryBooks and Periodicals. etc.

Seven tenders were received. Technical bids opened on 18.02.2016. Financial bids of eligiblebidders will be opened on 15.03.2016.

(iv) Recruitment for 110 sanctioned posts:

Process of recruitment against 110 sanctioned posts is in progress. Scrutiny of applicationsreceived against the advertisement has been completed. Experts for various selection committeeshave been nominated. A written test to shortlist the candidates for posts of faculty/hospital willbe held on 14th March, 2016. The recruitment process will be completed by July 2016.

Financial Progress

Table No. 11

(` in crore)

BE RE Expenditure (upto 29.2.2016) Shortfall

Plan 14.00 1.80 1.20 12.80

9.4 The Committee has noted from the information furnished that the under-utilisation of the budgetedfunds is due to slow progress of construction of the building and non-filling of vacant posts.

9.5 The Committee is constrained to observe that the proposal for establishment of NEIAH wasaccorded approval by the Cabinet way back in May, 2008. Almost nine years have elapsed sincethen, but the full operationalization of NEIAH is yet to be realised. The inordinate delay in fulloperationalization of NEIAH has resulted in the budgeted funds remaining under-utilized andsurrendered year after year. The Committee notes that as against the total approved outlay of`̀̀̀̀ 146.51 crore for the project, the RE during the first four years of the Twelfth Plan is only `̀̀̀̀ 49.72crore and the amount expended is even lower at `̀̀̀̀ 29.23 crore. The Committee observes that hadthe Ministry taken appropriate remedial measures to remove deficiencies in project formulationand implementation of the Project, obtained all clearances in time and streamlined its monitoringmechanism, the full operationalisation of the project could have been realised by now. The Committee,therefore, recommends even at the risk of sounding repetitive, that corrective steps may be takenfor addressing the recurrent problem of delays in implementation of this Project.

10. North Eastern Institute of Folk Medicine (NEIFM), Passighat

10.1 North Eastern Institute of Folk Medicine (NEIFM), Passighat, East Siang District, Arunachal Pradesh,which was established on 21st February, 2008, is a national institute under the Ministry of AYUSH which isbeing developed a Central of Excellence and apex research centre for all aspects of Folk Medicine knowledgewith linkages and collaboration with other research institution. The aims and objectives of NEIFM are to

21

survey, document and validate folk medicine practices, remedies and therapies prevalent in the North-EastRegion, with a view to revitalise, promote and harness local health tradition and flora.

10.2 As per information furnished to the Committee, the Twelfth Plan approved outlay for NEIFM is` 72.90 crore against which the total RE allocation from 2012-13 to 2015-16 is ` 24.37 crore and the actualexpenditure incurred is ` 16.02 crore as on 29th February, 2016. The original timeline for execution of theproject was January, 2010 which could not be adhered to due to various constraints including delay intransfer of 40 acres of land by the State Government. Subsequently, the Project was rescheduled to becompleted by June, 2011 but the timeline had again to be revised to October, 2013. The project is yet to befully operationalised which is evident from the submission of the Ministry that “the Institute will be fullyoperationalised in 2016-17”.

10.3 Informing the Committee about the physical and financial performance of NEIFM during 2015-16,the Ministry has furnished the following information:-

a. Physical Performance

(i) Construction works of NEIFM building completed.

(ii) Construction of Guest House completed.

(iii) Construction of Boundary Wall physically completed.

(iv) OPD Patients treated: 11,401 nos.

b. Financial Performance

Table No. 12

(` in crore)

BE RE Expenditure (upto 29.2.2016) Shortfall

Plan 6.40 1.70 1.50 4.9

10.4 The Ministry has cited the unspent balance and slow progress of construction work as contributoryfactors for financial under performance.

10.5 The Committee deprecates the Ministry for failing to fully operationalise the NEIFM whichaims to revitalise, promote and harness local health traditions of the North Eastern Region of thecountry, even after revising four times the time-line for its completion. The Committee hopes thatthe Ministry would fulfil its assurance to this Parliamentary Committee and fully operationalisethe NEIFW during 2016-17. The Committee desires to be kept apprised of the date of fulloperationalisation of NEIFM.

11. All India Institute of Ayurveda (AIIA)

11.1 The establishment of All India Institute of Ayurveda was approved on 21st January, 2008. The AIIAis conceived as an apex Institute for Ayurveda. As per information furnished by the Ministry, the Institutewill offer postgraduate and doctoral courses in various disciplines of Ayurveda and will focus on fundamentalresearch in Ayurveda, drug development, standardization, quality control, safety evaluation and clinicalresearch.

22

11.2 The Institute was targeted to be accomplished in the Eleventh Plan; however, it could not beoperationalized and 18 months time was allotted for completion of civil work from November, 2010 and therevised time-line set for completion of civil work was September, 2012. But the Institute could not be madefully operational even during 2014-15.

11.3 Apprising the Committee of the cost of the Project, the Ministry has submitted that it was initially`134.05 crore. However, later on it was revised to `157.00 crore. The cost escalation was made on someitems which were not taken earlier at the time of initial proposal.

11.4 An allocation of ` 25.00 crore had been made for AIIA for 2015-16 which was reduced to ` 2.49crore at RE stage. In reply to a question regarding the stark reduction in allocation for 2015-16, i.e., from` 25.00 crore in BE to ` 2.49 crore in RE, the Ministry has attributed the reason to slow progress onaccount of Statutory clearances from local bodies on account of which the building/Institute could not bemade fully functional due to which the AIIA was unable to initiate other services i.e. housekeeping,security, canteen, laundry, man power etc. Hence the anticipated expenditure on salary for all the proposedstaff and day to day expenditure on administrative and related activities could not be incurred.

11.5 Apprising the Committee of the physical performance of AIIA during 2015-16, the Ministry hadfurnished the following information:-

Physical Performance during 2015-16

(A) Construction and Procurement:

(i) Civil, Flooring, Aluminium work, False Ceiling and Internal service work is completed.

(ii) All basic and necessary equipment, machinery required to run a hospital are procured andplaced. Till date more than 70% equipment and machinery have been procured and rest are inpipeline. In regard to, services i.e. Laundary, Kitchen, Gasmanifold system, Mortuarycompleted Procurement of Panchakarma equipment is also fully completed.

(iii) Office and Lab furniture almost completed. Hospital furniture procured and being placed inthe rooms. Signage work is at an advanced stage of progress.

(iv) Electrical work and Permanent Electricity connection: AIIA got temporary load from M/sBSES required for testing of lift, fire & Medical Equipment.

(B) Recruitment of Staff:

(i) AIIA conducted Screening Test and Interview for different posts related to Faculty, HospitalServices and Administration & Finance on regular basis.

(ii) Posts of Professor and Associate Professor have been advertised and interviews will be heldshortly.

(iii) Post of Assistant Professor and one Dy. Medical Supdt. have been filled up. Offer ofappointment to selected candidates for different posts related to hospital and administrationare being sent. AIIA recruited staff on contractual basis against the sanctioned posts relatedto hospitals services.

(C) Miscellaneous :

23

(i) Out of nine lifts, six installed with permission and for remaining applied for permission.

(ii) Institute has occupied certain areas at Academic Block and OPD Block at the new buildingand started the OPD and Panchakarma facilities, Laboratory, Library, Administration andFinance.

(iii) Malaysian and US delegation have visited AIIA.

(iv) AIIA organized Cancer Day in Institute.

(D) Affiliation :

AIIA got affiliated from University of Delhi.

(E) Environment Clearance :

Institute got NOC from DPCC on ‘Consent to Establish’ the AIIA. Institute sent EnvironmentCompliance report to Ministry of Environment, Forest & Climate Changes, Lucknow.

(F) Academic Session & other course:

AIIA shall be starting one year Diploma course in ‘Panchakarma Technician Course’ from 2016-17.

Process of admission of other courses for 2016-17 has been started.

11.6 The Committee observes that the Ministry has not been able to utilise the budgetaryallocations for AIIA like other schemes mainly due to slow progress of construction andprocurement by M/s HSCC and delay in obtaining clearances from local bodies. The Committeeobserves that these impediments could have been overcome had the Ministry proactivelymonitored and pursued the matter with the implementing agency. The Committee expresses itsstrong displeasure at the tardy progress of implementation of the Project that has led to costescalation as well as surrender of the budgeted funds. The Committee recommends that theMinistry should evolve a strong monitoring mechanism under which periodic/quarterly meetingsshould be held to keep a track on the progress of operationalisation of the Institute. TheCommittee also desires the Ministry to ensure that there will be no further escalation of theproject cost.

12. Regulation and Quality Control of Ayurvedic, Siddha, Unani and Homoeopathic (ASU&H)Drugs

12.1 As per information given in the Annual Report 2015-16 of the Ministry, Ministry of AYUSH has aDrug Control Cell (DCC) to administer regulatory and quality control provisions for Ayurveda, Siddha,Unani and Homoeopathy (ASU&H) drugs. The Drug Control Cell deals with Drugs and Cosmetics Act, 1940and Rules thereunder and the associated matter pertaining to ASU&H Drugs. In this regard, the Cell coordinateswith the State Licensing Authorities and Drug Controllers to achieve uniform administration of the Act andfor providing regulatory guidance and clarifications. The cell also manages the implementation of the CentrallySponsored Scheme for Quality Control of ASU&H drugs under National AYUSH Mission (NAM) throughwhich grant in aid is provided for improving infrastructural and functional capacity of Drug Testing Laboratory& Pharmacies in the states for production, testing and quality enforcement of ASU drugs. The Secretariatfor two statutory bodies- Ayurveda, Siddha, Unani Drug Technical Advisory Board (ASUDTAB) and Ayurveda,

24

Siddha, Unani Drugs Consultative Committee (ASUDCC) is housed in the Drug Control Cell for planning,coordination and follow up action of their meetings.

12.2 The Drug Control Cell interacts with the Central Drug Standard Control Organization (CDSCO)Directorate General Foreign Trade, Ministry of Environment & Forests and Quality Council of India forWHO-GMP certification scheme, export/import and clinical trials related matters, availability issues of rawmaterials and quality certification in respect of ASU&H Drugs & industry related issues. In order to overseeeffective implementation of the Drugs & Cosmetics Rules regarding approval of ASU drug testing institutionsby the State Licensing Authorities, Technical Officers of the Ministry have been notified as Central DrugInspectors to undertake joint inspection of the ASU drug testing laboratories and report to the designatedauthority.

12.3 Replying to a query regarding the steps taken by the Ministry to strengthen certification and regulatorysystem of ASU&H drugs, the Secretary, Ministry of AYUSH during his evidence before the Committee onthe 21st March, 2016 submitted that the major lacuna in the quality control of AYUSH products is that“licensing of new products is with the State licensing authorities. They are very ill-equipped, both technicallyand infrastructurally, to handle this task. Many states do not have AYUSH Inspectorates. It is the allopathicside which does it and for them it is very low priority. It is very easy to convince them about a new drugwith new indications.”

12.4 The Secretary also submitted that one of the components of the National AYUSH Mission is tosupport strengthening of testing laboratories, infrastructure and pharmacies. But the whole framework isvery weak and the testing laboratories are ill-equipped technically. The State Licensing Authorities do notknow how to give licence to a new drug with new indications.

12.5 Responding to a query regarding the action taken against the misleading advertisements makingexaggerated claims about the efficacy of AYUSH remedies, the Secretary (AYUSH) submitted that apartfrom the weak licensing authority at the State level, the major weakness was that there is no definition ofa new drug. All that is required for giving license to a new drug is that the manufacturer should go andgive some proof of effectiveness and safety of the drug (e.g. showing an article published on a AYUSHremedy) which is treated as proof of efficacy and safety of the drug. He also submitted that to find asolution to this problem, the Ministry of AYUSH is formulating rules regarding definition of a new drugand its efficacy. The new rules warrant that unless detailed clinical trials of a new drug are conducted tovalidate its efficacy and safety as per the guidelines prescribed, the State Licensing Authority cannot givelicense to the new drug.

12.6 On the issue of misleading advertisements making exaggerated claims about the efficacy of ASU&Hdrugs, the AYUSH Secretary submitted that the this was due to the ineffectiveness of the Drugs and MagicRemedies (Objectionable Advertisements) Act, 1956. He informed the Committee that a new set of ruleshave been drafted for effective regulation of contents of such advertisements and the rules will be notifiedas soon as they are vetted by Ministry of Law and Justice.

12.7 On being asked about the updated status of setting up of a Central Drug Regulator for AYUSH, theMinistry in a written submission has stated that the proposition of setting up Central Drugs Controller forAYUSH was reviewed on the direction from PMO in a meeting on 5th March, 2015 chaired by Hon’bleMinister of Health and Family Welfare wherein it was recommended to have a vertical structure for regulationof AYUSH drugs in the Central Drugs Standards Control Organization (CDSCO) and the need for creation of

25

separate Drug Controller General of AYUSH may be assessed subsequently. Accordingly, setting up of astructured Central Regulatory Framework for AYUSH drugs has been taken up by the Department of Healthand Family Welfare. In this regard, Ministry of AYUSH has provided relevant inputs to the Department ofHealth and Family Welfare and the progress is followed up regularly.

12.8 The Ministry in its written submission has also informed that the Department of Health and FamilyWelfare has informed that approval of Cabinet would be required to set up the proposed central verticalstructure for regulation of AYUSH drugs and the likely proposal now would be to prepare a completely newBill on consideration of the amendment of Drugs & Cosmetics Act, 1940 by the Group of Ministers. Ministryof AYUSH has notified creation of twelve posts of Deputy / Assistant Drug Controllers and Inspectors ofASU&H on 17th February, 2016 and Recruitment Rules for these posts are being processed for seekingapproval of the Department of Personnel and Training and Union Public Service Commission.

12.9 Responding to a query regarding the status of regulation of dispensing of AYUSH pharmacy, theSecretary (AYUSH) submitted that as of now there is no regulation in the field of AYUSH pharmacy. Hestated that for the purpose of regulation of dispensing of AYUSH pharmacy, the Indian Medicine andHomoeopathy Pharmacy Central Council, 2016 has been circulated for inter-ministerial appraisal and publiccomments. Once the Act is enacted everything will be standardized in this regard.

12.10 In response to a query of the Committee regarding concrete steps taken by the Ministry to strengthenregulatory mechanisms of ASU&H drugs, the Ministry in a written reply informed that an amendment wasrequired in the provisions of Drugs and Cosmetics Act 1940 and the necessary inputs for setting up thevertical structure for regulation of ASU&H drugs had been forwarded to Department of Health and FamilyWelfare. Drugs and Cosmetics Rules, 1945 pertaining to ASU&H drugs are amended in consultation withthe Ayurvedic, Siddha and Unani Drugs Technical Advisory Board (ASUDTAB), which is a statutory bodyunder the provisions of Drugs and Cosmetics Act, 1940. Actions had been initiated on the recommendationsof the ASUDTAB and nine officers of the Ministry had been appointed as central inspectors for carrying outJoint Inspection of the laboratories seeking approval under Drugs, and Cosmetics Rules, 1945 for testing ofASU&H drugs and raw materials. Creation of 12 posts of Deputy/Assistant Drug Controller and Inspectorshad been notified and financial support provided to the states through National AYUSH Mission to strengthenthe enforcement framework and testing of drugs.

12.11 The Ministry has also informed in a written reply that a central scheme for safety monitoring ofAyurvedic, Siddha, Unani and Homoeopathy drugs has been drafted, which will be finalised withinterdepartmental consultative process for seeking approval of the Standing Finance Committee. Objectiveof the scheme is to develop a network of peripheral, regional and National centres, who could implement theprogram of Pharmacovigilance and it is intended to initiate the pharmacovigilance programme under the aegisof All India Institute of Ayurveda, which is an upcoming institute likely to be operationalized in 2016-17.

12.12 The proposed pharmacovigilance initiative is contemplated with the aim for developing a system ofreporting, compilation, analysis and management of Adverse Drugs Reactions of ASU&H drugs used by thepeople and allied matters of drugs.

12.13 The Ministry in a written submission has also informed that the Centrally Sponsored Scheme ofQuality Control of ASU&H drugs was started since Ninth Plan and continued till Twelfth Plan. Mid-termThird Party evaluation was made in the year 2013. A revised scheme was prepared and merged in NationalAYUSH Mission in September, 2014 for better functioning of the State Drug Control Mechanism, Pharmacies

26

and Drug Testing Laboratories for testing of ASU&H drugs. Under the Drugs Quality Control Schemegovernment has assisted 27 State Drug Testing Laboratories and 46 State Pharmacies, State EnforcementMechanism for the development of AYUSH in the country during the Ninth to Twelfth Plan.

12.14 The Committee observes that to enhance the acceptability of ASU&H medicines within thecountry and abroad, the quality control and standardization is of prime importance, but the regulatoryframework of certification and quality control of AYUSH remedies is very weak, which raises seriousconcerns regarding safety issues. The Committee in its Reports on Demands for Grants of theMinistry of AYUSH (erstwhile Department of AYUSH) has been commenting on quality assuranceand standardization of Ayurveda, Siddha, Unani and Homoeopathic medicines and urging the Ministryto speed up strengthening and streamlining of regulatory mechanism of ASU&H drugs. TheCommittee is aware that there is a separate Chapter-IV A in the Drugs and Cosmetics Act, 1946which regulates the manufacture and sale of ASU drugs. Since the enforcement of provisions ofDrugs and Cosmetics Act and Rules made thereunder is under the purview of State Drug Licensingand Drug Control Authorities, the State Drug Regulatory Framework has a crucial role to play inensuring safety and quality of ASU and H drugs. It is in this context that the Committee views withseriousness the submission of the Secretary (AYUSH) that the State Drug Regulatory framework isvery weak and State Drug Licensing Authorities are very ill-equipped both technically andinfrastructurally, to handle the task of regulation of AYUSH medicines. The Committee also takesnote of the submission of the Secretary (AYUSH) that it is the allopathic side which does the regulationof AYUSH medicines and the AYUSH industry regulation gets neglected because the State regulatorsare more focussed on modern medicine than on AYUSH products as a result of which regulatoryneeds of standardization and quality control of ASU&H drugs get seriously impaired. The Committeealso observes that quality control and standardization of ASU&H drugs, which are mainly herbal/herbo-mineral preparations, is very complex and different from synthetic molecules of the allopathicsystem which are produced under controlled laboratory conditions. Taking all these facts into account,the Committee recommends that the Government should move quickly towards setting up a separateregulator for AYUSH industry and apprise the Committee of the time-frame within which a separateregulator for AYUSH industry would be set up. The Committee also desires to be apprised of therecommendation of the AYUSH Task Force set up by Government under Chairmanship of Prof. H.R. Nagendra on the issue of regulator for the AYUSH industry.

12.15 The Committee also recommends that the Ministry should avoid the prolonged andprocrastinated discussion with the concerned entities on the issue of creating a separate regulatorystructure for the AYUSH industry and iron out all inter-ministerial issues within a span of threemonths from the presentation of this Report.

12.16 The Committee also observes that the quality assurance of the ASU&H drugs cannot beachieved by creating a separate regulatory structure for the AYUSH industry alone. A host of otherissues like creation of new drug testing laboratories and equipping them with the state-of-the-arttechnology to enable them to carry out sophisticated analysis of AYUSH drugs, upgradation of theexisting Central Drug Testing Laboratories, implementation of an effective result-orientedpharmacovigilance programme, etc. will also have to be addressed to achieve the desired objectives.The Committee, therefore, recommends that a clear roadmap for creation of new drug testinglaboratories equipped with the state-of-the-art technology, capacity building of the existing

27

laboratories, upgradation of the existing Central Drug Laboratories and implementation of a robustpharmacovigilance programme to collect adverse drug reaction data in a systematic manner, maybe chalked out and implemented without further delay. The Committee desires to be kept apprisedof the steps taken and the progress made in this regard.

12.17 The Committee in its earlier Reports has been commenting upon the misleadingadvertisements concerning AYUSH remedies over TV and radio and in the print media and exhortingthe Ministry to take necessary remedial measures in preventing inappropriate advertisements inelectronic and print media. The oft-repeated contention of the Ministry in this regard has been thatdue to ineffectiveness of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954,it has not been possible to take stringent action against the misleading and exaggerated claims ofefficacy of the AYUSH remedies. Subsequently, the Ministry constituted on the recommendation ofthe Committee, a Task Force for the purpose of suggesting amendments in the aforesaid Act. TheMinistry in its Action Taken Notes on the 84th Report of the Committee had inter-alia informedthat Department of Health and Family Welfare, under whose jurisdiction Task Force for suggestingamendments in the Drugs and Magic Remedies Act, 1954 was constituted, has been requested toexpedite consolidation of the amendment provisions recommended by the Task Force. The Committeenotes that there has been recurring delays in amending the Drugs and Magic Remedies (ObjectionableAdvertisements) Act, 1954 and Rules framed thereunder. Though the process of amending the saidAct and Rules has been set in motion, its logical culmination is still some distance away. TheCommittee, therefore, recommends that the Ministry should vigorously pursue the matter ofamending the said Act and Rules thereunder. The Committee also recommends that apart fromgiving sharper teeth to the Drugs and Magic Remedies Act, a provision should also be incorporatedin the relevant Rules to ban such practices and penalise offenders.

12.18 It is a matter of serious concern for the Committee to note that there is no proper definitionof what a new drug is and there are no stringent norms requiring the manufacturer to providerigorous proof of both, safety and efficacy of a new AYUSH drug and license to a new drug is givenwithout proof of efficacy and safety. The Committee, therefore, welcomes the decision of the Ministryon framing rules requiring the manufacturer to subject a new drug to clinical trials before thelicense is given to the same by the State Drug Licensing Authority. The Committee exhorts theMinistry to proactively pursue finailization and notification regarding definition of what a new drugis. The Committee desires to be kept apprised of the progress made in this regard. 12.18 TheCommittee observes that there are two categories of existing drug formulations. One category hasmain classical formulations. The other category has drugs which have been introduced in the marketas patent and proprietary drugs over the last 20-30 years. All kinds of exaggerated claims have beenmade on the labels of these patent and proprietary drugs about their efficacy in treating variousdiseases including cancer, obesity, hypertension etc. The Committee notes that the Ministry isworking on enforcing stricter definition of a new drug prospectively. But the damage has been doneby all such drugs as have been introduced in the market in the last ten years, without rigorousproof of efficacy and safety. The Committee, therefore, recommends that it is imperative for acredible regulatory and certification system that manufacturers of all patent and proprietary ASU&Hdrugs which have been introduced in the market in the last ten years, should be required to provetheir efficacy and safety through clinical trials over the next five years. The Committee wishes tobe apprised of the concrete action taken in this regard.

13. National AYUSH Mission (NAM)

28

13.1 As per information in the Annual Report 2015-16, the National AYUSH Mission (NAM) is the CentrallySponsored Scheme of the Ministry of AYUSH which was launched on 15.09.2014. National AYUSH Missioninter-alia envisages better access to AYUSH services through increase in number of AYUSH Hospitals andDispensaries and ensure availability of AYUSH drugs and trained manpower. It also aims at improvement inquality of AYUSH Education through enhancement in the number of upgraded AYUSH educational Institutions,improvement in availability of quality ASU &H drugs through increase in number of Pharmacies and settingup of Drug Laboratories in the states which are responsible for enforcement mechanism of ASU &H drugsand sustain availability of quality raw materials by promoting Medicinal plants.

COMPONENTS

13.2 The main components/activities of NAM include Core/Essential activities which is allocated 80% ofthe Mission and Flexible Components which is allocated 20% of the Mission allocation.

13.3 During the course of his deposition before the Committee on 21st March, 2016, the Secretary,AYUSH made the following submissions about the components of the NAM:----

Components Percentage allocation

AYUSH Services 58.81

AYUSH Educational Institutions 1.96

Quality Control of ASU & H Drugs 3.91

Medicinal Plants 11.32

20% resource pool is for flexible components for meeting local needs as well as encouraginginnovations

13.4 Apprising the Committee of the progress made under the NAM, the Secretary, AYUSH made thefollowing submissions:-

Table No. 13

COMPONENT No. of units covered in No. of Units covered2014-15 in 2015-16

Co- location at PHCs, CHCs and DHs 5716 4585

Upgradation of AYUSH Hospitals and 5770 1608Dispensaries

50 bedded Integrated AYUSH Hospitals 5 14

Supply of Essential drugs 11743 14387

Upgradation of AYUSH Educational Institutions 37 S N

Strengthening of State DTLs, Pharmacies 11 25

Medicinal Plants - 8662.91 Hects. Area coverageunder cultivation, 6 ModelNursery, 26 Small Nursery, 36drying sheds, 25 storagegodowns

29

13.5 Replying to a query regarding the objective of the Mission, the Secretary submitted that the basicobjective of the Mission is to mainstream services to the public at large. He further submitted that theMission aims at establishing an AYUSH facility along with every allopathic facility in the next four or fiveyears so that the patient has a choice of which facility he wants to use. He further informed the Committeethat there are approximately 25,000 PHCs and AYUSH facilities are co-located in 10,042 Primary HealthCentres. Apart from that, there are standalone AYUSH facilities in many states.

13.6 The Committee observes that India has a rich heritage of AYUSH systems of medicinesand therapies and co-location of AYUSH facilities with allopathic facilities will not only providepeople options to avail treatment of their choice but also help bridge the gaps in healthcare. SinceMission means to have a performance objective, a cost objective and a time objective, the Committeewould like the Ministry to fix quantitative targets in terms of the above objectives for 2016-17and test the success of the National AYUSH Mission on the touchstone of these three objectives.The Committee desires to be apprised of the achievements made vis-à-vis targets set under theNAM for 2015-16.

13.7 The Committee feels that it would be difficult to step up the process of mainstreaming ofAYUSH without standardizing drugs and treatment protocols of AYUSH therapies. The Committeewould, therefore, like the Ministry to devote its attention towards nurturing AYUSH systems ofmedicines through standardization of drugs and treatment protocols.

14. National Medicinal Plants Board (NMPB)

14.1 As per the information in Annual Report 2015-16, India has the unique distinction of possessing asubstantial bio-diversity of medicinal plants, knowledge associated with their use and a good network ofinfrastructure required for their promotion, propagation etc. Indian systems of medicine use various rawmaterials and medicinal plants constitute 90% of it. About 3000 plants species are reported to be used inthe codified Indian Systems of medicines like Ayurveda (900 species), Siddha (800 species), Unani (700species) and Amchi (300 species). The rest of the species are used in local health traditions and in folksystems of medicine. Medicinal plants thus constitute an important component of the plant resourcewealth of our country. In addition to their use in the preparation of Traditional medicines, the medicinalplants are being used in preparation of various pharmaceuticals and health products under the modernmedicine system.

14.2 Keeping in view the need for availability of authentic raw drugs, the vast potential of herbal product/herbal drugs and the role India could play in the global market, Government of India has taken the lead byestablishing National Medicinal Plants Board (NMPB) under Ministry of AYUSH, Government of India.NMPB is an apex national body which coordinates all matters relating to medicinal plants in the country.

14.3 The Ministry has informed the Committee that NMPB under Centrally Sponsored Scheme on MedicinalPlants promoted cultivation of medicinal plants. The scheme is merged with under National AYUSH Mission(NAM) as a component of Medicinal Plants Cultivation. NMPB under NAM for medicinal plants componentalso supports forward and backward linkages of MPs cultivation from Nursery for quality planting materialto storage, processing and market linkage. State specific action plans are prepared according to the localdemands by National Horticulture Missions and then approved by NMPB and NAM. NMPB has also taken-up species specific campaigns for promotion of medicinal plants which are becoming less and are high indemand e.g. Amla, Ashoka, Guggal etc.

30

14.4 On being asked about the steps taken for proper sale and marketing of medicinal plants, the Ministryin a written reply has submitted that:----

(i) Medicinal Plants (MPs) market as well as the supply chain of MPs is highly unorganized andfragmented which needs to be institutionalized. Hence, to assess the Demand and Supplyposition of MPs in the country, NMPB had conducted a study with Foundation for Revitalisationof Local Health Traditions (FRLHT) in 2007. To update the current scenario of demand andsupply of MPs in the country, fresh study has been commissioned by NMPB to Indian Councilfor Forest Research & Education (ICFRE), Dehradun.

(ii) NMPB under Central Sector Scheme for Conservation, Development and SustainableManagement of Medicinal Plants can support the market related activities eg. Creation of MPsmandies, Minimum Support Price (MSP) for medicinal plants. The State Medicinal PlantsBoards (SMPBs), Forest Departments and other Stakeholders have been asked to work andprepare projects on market related activities of MPs.

(iii) State Agricultural Universities, Facilitation Centres have been asked to facilitate establishmentof herbal mandies in respective states where farmers can sell their produce at fair price.

(iv) Organized buyer-seller meeting at various levels through state agencies, facilitation centres,NGOs, Research Organizations etc.

(v) Organized a brain storming session involving all the stakeholders to discuss the issues, challengesrelated to medicinal plants marketing wherein FEDMAP and FRLHT have been asked to preparea road-map for institutionalization of MP market.

(vi) For development of Linkages between farmers, traders and manufacturers, NMPB has beenconstituted a “Co-ordination Group” with the ASU drug manufacture associations.

(vii) In collaboration with Choudhary Brahm Prakash Ayurved Charak Sansthan, Najafgarh, NewDelhi NMPB organized a Buyer-Seller Meet on 29th February 2016 to facilitate the marketingchannel between farmers, traders and manufacturers. A good interaction has been taken betweenmany farmers and manufacturers participated in the said meeting.

14.5 The Committee notes that to update the current scenario of demand and supply of MedicinalPlants in the country, the Ministry has commissioned a fresh study under Indian Council ofForest Research and Education (ICFRE), Dehradun. The Ministry should proactively pursueconclusion of the study within a given time-frame. The Committee desires to be apprised of thefindings of ICFRE and action taken thereon by the Ministry. The Committee also wishes to beapprised of the blueprint to be prepared by FEDMAP and FRLHT for institutionalization of MPmarket.

15. Scheme for Grant-in-Aid to Non-Profit/ Non-Governmental AYUSH Organisations /Institutionsfor Upgradation to Centres of Excellence

15.1 As per the information furnished in the Annual Report 2015-16. it is a Central sector grant-in-aidscheme introduced in 2007-08 for the 11th Five-year Plan period and continued in the Twelfth

Plan. The

main objectives of the scheme are to support reputed AYUSH knowledge institutions in non-Government /private sector engaged in the activities of clinical research, Nursing hospitals and homes, fundamental of

31

AYUSH, inter-disciplinary research in pharmacy or product development, bridging AYUSH and modernscience, AYUSH informatics etc., to upgrade their functions and facilities to levels of excellence.

15.2 So far, Ministry of AYUSH has sanctioned total 30 Projects during the Eleventh Plan and TwelfthPlan with estimated cost of `103.65 crore, out of which `80.50 crore has been released as 1st, 2nd & 3rdinstallment to the Grantee institutions.

15.3 As per the information given by the Ministry, the financial performance of the scheme during 2015-16 is as under:-

Table No. 14

BE RE AE Excess Reasons for variation(29.02.2016) (+)/Savings (-)

20.00 13.00 11.34 -8.66 Savings are due to unspentbalance of the previous year andreceipt of less proposals. Thebalance amount w.r.t RE will befully utilized in March, 2016.

15.4 In reply to question regarding the physical and financial performance of the above programmeduring 2015-16, the Ministry has informed that during 2015-16, Grant-in-aid of ` 11.28 crore was releasedto 8 ongoing projects which are at different stages of completion.

15.5 In reply to another query as to whether the structure of the above Programme has been reviewedand modifications made to attract proposals under the Programme, the Ministry has informed that in orderto attract more proposals and to enhance the scope of the scheme, the Ministry is reviewing the SchemeGuidelines for carrying out modifications in the Scheme guidelines. In this regard, internal deliberationswere held in the Ministry, opinion of experts were taken and meeting was also convened with eminentexperts and reputed organisations including AIIMS. Based on the suggestions received from the experts, thescheme guidelines are being modified and are at advanced stage of finalization.

15.6 For proper dissemination of the information in regard to the Scheme, the Ministry of AYUSH hasuploaded the guidelines of the Scheme on website for both languages (Hindi and English) to invite freshproposals.

15.7 Road shows have also been conducted in two States namely West Bengal and Uttarakhand to givemore publicity and create awareness about the scheme. Recently Reminder letters have been sent to allNorth-Eastern States Health Secretaries requesting for proposals.

15.8 The Committee observes that for making full use of all research capacity in the field ofAYUSH in the country, activities and innovations in private and non-voluntary sector would need tobe supported financially, particularly in the wake of the fact that majority of the AYUSH institutionsare in the private sector. Since the prime objectives of the scheme for Grant-in-Aid to Non-profit/non-governmental institutions are to support AYUSH knowledge institutions engaged in clinicalresearch, inter-disciplinary research in pharmacy or drug development, bridging the gap betweenAYUSH and modern science, etc. this scheme is of vital importance from the point of view of

32

fostering collaborative and inter-disciplinary AYUSH research. The Committee, therefore, welcomesthe initiative of the Ministry towards holding deliberations with eminent experts and reputedorganisations including AIIMS for the purpose of carrying out modifications in the scheme. TheCommittee expects the Ministry to expedite finalization of the revised scheme at the beginning ofthe Financial Year 2016-17. The Committee would like to be apprised of the efficacy of the revisedscheme in ensuring prompt receipt of proposals from the stakeholders.

16. Research Councils

16.1 The Committee has been informed that there are five apex research councils under the Ministry ofAYUSH, namely

(i) Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi

(ii) Central Council for Research in Unani Medicine (CCUM), New Delhi

(iii) Central Council for Research in Homoeopathy (CCRH), New Delhi

(iv) Central Council for Research in Yoga and Naturopathy (CCRYN), New Delhi

(v) Central Council for Research in Siddha (CCRS), Chennai

16.2 The Committee has been provided the following information on the financial performance of theresearch councils during 2015-16:----

Table No. 15

(` in crore)

Sl. Name of Council BE RE Expenditure No. (upto 29.2.2016)

Plan Plan Plan

1 CCRAS 76.70 96.00 92.00

2 CCRUM 66.00 42.66 42.04

3 CCRH 58.00 60.00 45.96

4 CCRYN 13.00 17.05 10.80

5 CCRS 9.50 7.32 6.24

(i) Central Council for Research in Ayurvedic Sciences (CCRAS)

16.3 The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body underMinistry of AYUSH, Govt. of India which is an apex body for undertaking, coordinating, formulating,developing and promoting research on scientific lines in Ayurveda. The main activities of the Council compriseClinical research, Drug research (Medicinal plant research, Drug Standardization & Quality Control,Pharmacology research) and Literary research.

Achievements

16.4 In reply to a query regarding achievements of the Central Council for Research in Ayurvedic Sciences(CCRAS) during the last 3 years, the Ministry has informed that the CCRAS had conducted clinical research

33

for validation of Ayurvedic drugs/therapies on various diseases conditions such as Diabetes, RheumatoidArthritis, Osteoarthritis, Bronchial Asthma, Anaemia, Mental Retardation, Hypertension, Obesity etc. through87 projects.

(ii) Central Council for Research in Unani Medicine (CCRUM), New Delhi

16.5 The Central Council for Research in Unani Medicine (CCRUM), an autonomous organization ofMinistry of AYUSH was established in the year 1978. The Council started functioning from 10 January1979.

Research Programmes

16.6 The research areas include clinical research, drug standardization research, survey and cultivationof medicinal plants programme and literary research. Besides, information, education and communication(IEC) activities and research oriented extension health services are also part of the council’s programmes.Activities in the above areas were continued during the reporting period.

Clinical Studies On New Investigational Drugs

16.7 The Committee has been informed that during 2015-16 multi-centric randomized controlled trials(RCTs) in four diseases viz; Bars (Vitiligo), Zaghtuddam Qawi Lazmi (Essential Hypertension), ZiabetusSukkari (Diabetes mellitus), Iltehab-e-Kabid (Infective hepatitis) were continued. A total of 4102 new patientswere registered during the reporting period. Open label and comparative trials on new investigational drugsin Bars (Vitiligo), Iltehab-e-Tajaweef-e-Anf (Sinusitis), Daus Sadaf (Psoriasis), Waja-ul-Mafasil (Rheumatoidarthritis), Tahajjur-e-Mafasil (Osteo arthritis) and Iltehab-e-Kabid (Infective hepatitis) continued at differentcentres of the Council.

Collaborative Studies

16.8 The Committee has been informed that during 2015-16 four new collaborative studies one each inVitiligo at Department of Dermatology All India Institute of Medical Science, New Delhi; Diabetes mellitus atDepartment of Pharmaceutical Analysis, SPP School of Pharmacy & Technology Management, Mumbai;Autism at FSMHP-UDAAN for the Disabled, New Delhi and redesigning of Unani formulations at AK TibbiaCollege, AMU, Aligarh were initiated.

16.9 Under the MoU signed with ICMR, modalities completed for collaborative studies on PulmonaryTuberculosis with National Institute for Research in Tuberculosis (NIRT), Chennai and Regional ResearchInstitute of Unani Medicine (RRIUM), Chennai and on Cervical Erosion with Institute of Cytology andPreventive Oncology (ICPO), Noida and Regional Research Institute of Unani Medicine (RRIUM), Aligarh.Protocols for the studies were finalized and preliminary work initiated.

(iii) Central Council for Research in Homoeopathy (CCRH)

16.10 The Committee has been informed that the CCRH is engaged in multi-dimensional research in thefields of Survey, Collection and Cultivation of Medicinal plants, Drug Standardisation, Drug Proving, ClinicalVerification, Clinical Research, Fundamental and Basic Research in Homoeopathic system of medicine tomake homoeopathy more plausible through evidence based research.

16.11 On being asked about the evaluation of the research projects of CCRH the Ministry in a written replyhas furnished the following information:

34

(i) Monitoring of research projects on monthly basis by the Nodal officers at CCRH Hqrs. Thenodal officers also visit for field monitoring for reviewing the progress in the projects.

(ii) Evaluation of progress by Special Committees constituted by President of the Governing Bodyat least twice in the year. Four Special Committees have been constituted for Clinical Research,Drug Standardization, Drug Proving and Fundamental and Basic research.

(iii) Review by Scientific Advisory Committee twice in a year.

(iv) Review by Governing Body at least once in a year.

16.12 Regarding the roadmap to improve the quality of research projects of CCRH, the Ministry hasfurther informed that Council has initiated infrastructural strengthening of laboratories in the Central andRegional Research Institutes for collecting information on laboratory markers (chemical, pathological andbiological, radiographic etc.) for evidence based outcome of the results; Regular training of research scientistsfor capacity building; Exposure of scientists to international standards about research modules; and Regularvisits of experts from Special Committees and Scientific Advisory committees for field monitoring.

Clinical Research

16.13 The Committee has been informed that clinical research is the core area of homoeopathic research.

Ongoing Studies

16.14 The following information is given in the Annual Report:-

1. Effectiveness of homeopathic medicines-vs-placebo as add on to institutional managementprotocol for Acute Encephalitis Syndrome (AES) – A randomized open label controlled trial.

2. A randomized placebo controlled, cross-over, clinical trial of homoeopathic medicine in Autism.

3. Homoeopathy as adjunctive treatment to Resperidone/ Olanzapine in treatment resistant patientsof Schizophrenia: an open label randomized placebo controlled trial.

4. Adjuvant homoeopathic management for cancer patients experiencing side effects fromchemotherapy-An observational pilot study.

5. A multi-centric single blind randomized placebo controlled trial to evaluate the efficacy ofindividualized homeopathic intervention in Breast Fibroadenoma.

6. Effects of individualized homoeopathic intervention in Dyslipidemia: an open label randomizedcontrolled exploratory trial.

7. Effects of homoeopathic intervention in Stage I Essential Hypertensive Patients: A randomizeddouble blind, placebo controlled trial.

8. Effects of homoeopathic intervention in Pre-Diabetes (EHIP): an open label randomizedcontrolled exploratory trial.

9. Management of Polycystic Ovarian Syndrome with homoeopathic intervention versus placebo-A randomized controlled pilot study.

10. An open label (pre and post-homoeopathic intervention) study to evaluate efficacy ofhomoeopathic treatment of non-erosive gastroesophageal reflux disease (NEGERD).

35

11. Homoeopathic Therapy for lower urinary tract symptoms in men with Benign ProstaticHyperplasia: An open randomized multicentric clinical trial.

12. Efficacy of homoeopathic treatment for Diabetic Distal Symmetric Polyneuropathy: amulticentric randomized double blind placebo controlled clinical trial.

(iv) Central Council for Research in Yoga and Naturopathy (CCRYN)

16.15 Central Council for Research in Yoga and Naturopathy (CCRYN) is an autonomous body underMinistry of AYUSH, Government of India registered under Society Registration Act for conducting scientificresearch, training and propagational activities in the field of Yoga and Naturopathy.

Achievements

16.16 As per the information given in the Annual Report 2015-16, the following are the achievements ofCCRYN:-

16.17 During 2015-16, Clinical Research studies were ongoing at various premier Medical, Yoga andNaturopathy institutions for establishing the efficacy of Yoga and Naturopathy in prevention and managementof various disease conditions. The Council has also published the research findings of completed ResearchProjects in the form of Research Monographs. The Council has published 13 monographs and completed 41research projects till date. Two research papers have been published during 2015-16. A total of 51 researchpapers have been published by the Project Investigators so far.

(v) Central Council for Research in Siddha (CCRS)

16.18 Central Council for Research in Siddha was established, as per the cabinet approval, by bi-furcatingthe erstwhile Central Council for Research in Ayurveda and Siddha to promote more focused research inSiddha system of Medicine.

Clinical Research

16.19 In clinical research 3 projects under IMR were approved and the fund was sanctioned to respectiveinstitutes. Out of 3, 2 projects are multicentric. IEC approval was obtained from 3 institutes and from 1institute it is yet to be obtained. The recruitment of project staff and purchase of equipments are in progress.

16.20 The Committee takes note of the various research projects of the Research Councils andobserves that no amount of pure research will be able to meet the needs of our health system unlessthe knowledge generated through research projects leads to efficacious health interventions andinnovations that could help realization of AYUSH potential in healthcare. The Committee would,therefore, like to be apprised about the research leads generated through research projects of thefive research Councils that have been translated into specific health products/ processes.

16.21 The Committee also recommends that the Research Councils of the Ministry of AYUSHshould be benchmarked with the best research institutions in their domain at international level sothat the Research Councils could emulate them and achieve high levels of performance. TheCommittee also recommends that there should be clearly articulated transparent criteria for appraisaland evaluation of their research projects with regard to their impact on the health system.

36

OBSERVATIONS/RECOMMENDATIONS — AT A GLANCE

Recommendation/Observation

Budgetary Allocation

The Committee observes from Table No. 2 that as against the total Twelfth Plan approvedoutlays of `̀̀̀̀ 10044.00 crore, the total allocation made in RE from 2012-13 to 2015-16 is `̀̀̀̀ 2786.78crore and the expenditure incurred as on 29th February, 2016 is `̀̀̀̀ 2362.93 crore only. The Committeenotes from Table 1 that the actual expenditure has invariably been considerably lower than theRevised Estimates in 2012-13 and 2013-14 and slightly lower in 2014-15. Despite the fact that a ZeroBased Budgeting exercise which requires that budget request be evaluated thoroughly, startingfrom the zero base, was undertaken at the beginning of the Eleventh Plan, a substantial amount of`̀̀̀̀ 423.85 crore of the budgeted funds could not be utilised during the first four years of the TwelfthPlan period, which is a matter of serious concern. The Committee is constrained to observe thatsuch a substantial gap between the RE allocations and the actual expenditure is indicative of fiscalindiscipline and unrealistic projection of estimates. Had the Ministry assessed requirement of fundsrealistically and monitored their deployment diligently such a shortfall in utilization of the budgetedfunds could have been avoided and the unspent amount utilized more gainfully somewhere else.The Committee, therefore, recommends that a comprehensive analysis of the trend of expenditureincurred under various heads of the Ministry during the last four years be carried out with a view torectifying and improving upon the existing system of assessing fund requirement. The Committeewould also expect the Ministry to make its estimates only after proper assessment and planning infuture. (Para 2.18)

The Committee notes that the Ministry has been allocated `̀̀̀̀ 1050.00 crore in BE 2016-17 onthe plan side against the projected demand of `̀̀̀̀ 1819.77 crore and thus there is a shortfall of`̀̀̀̀ 769.77 crore. The Committee takes note of the submission of the Secretary (AYUSH) that “wewill be able to achieve almost hundred percent utilization” of the funds budgeted for 2015-16 andthat the goals of the National AYUSH Mission will be affected due to the shortfall in allocation for2016-17. The Committee observes that health needs of a vast and diverse country like India cannotbe met by a single healthcare system and AYUSH healthcare systems, which besides being curative,are also preventive and promotive healthcare systems, have a vital role to play in expanding theoutreach of healthcare to the people because of their inherent advantages in terms of diversity,modest cost, low level of technological input, etc. The shortfall in allocation for 2016-17 will haveadverse impact on the key priorities of the National AYUSH Mission which aims at mainstreamingof AYUSH, improving quality of ASU&H drugs, setting up of drug laboratories, improvement inAYUSH education etc. The Committee observes that the BE 2016-17 allocation of `̀̀̀̀ 1050.00 crore islower than the BE 2013-14 and 2014-15 allocation of `̀̀̀̀ 1069.00 crore each and is only marginallyhigher than the allocation of `̀̀̀̀ 1008.00 crore in BE 2015-16. The Committee observes that in aresource-constrained country like India, it is extremely difficult to meet the demands for funds,however genuine, of the Ministry in full and therefore in order to obtain the best possible health

36

37

outcomes, it is imperative that allocation of resources is prioritized across competing ends. TheCommittee would, therefore, like the Ministry to work out the bare minimum additional increasethat the Ministry needs in its budget for 2016-17 for carrying out activities/programmes which areabsolutely essential and cannot be postponed till next year and approach the Ministry of Finance forallocating that amount through supplementary grants. The Committee desires to be kept apprisedof the response of Ministry of Finance in this regard. (Para 2.19)

The Committee notes that as compared to the BE 2016-17 allocation of `̀̀̀̀ 31300.00 crorefor the Department of Health and Family Welfare, the Central expenditure on AYUSH for2016-17 is `̀̀̀̀ 1050.00 crore only. State Governments are spending much more on AYUSH than theUnion Government. To make an in-depth analysis of total Government expenditure on AYUSH,the Committee would like the Ministry to collect and furnish information to the Committee onthe total Government expenditure on AYUSH (i.e. combined spending on AYUSH by the Centreand all States) as also the Centre-States ratio in total Government expenditure on AYUSH. TheCommittee would also like to know whether any policy pronouncement of raising AYUSH sharein total Government expenditure on health had been articulated in the Twelfth

Five Year Plan.

(Para 2.20)

The Committee’s scrutiny of Table No. 5 reveals that for 14 heads of account, budgetaryprovisions had been obtained in BE 2015-16 but not a single rupee was spent. Of the 14 schemes, thebudgeted funds of as many as nine schemes could not be utilised due to non-approval of the schemes.For example, `̀̀̀̀ 15.00 crore had been allocated at the stage of BE 2015-16 for “All India Institute ofUnani Medicine” but nothing was spent and the entire allocated amount of `̀̀̀̀ 15.00 crore wassurrendered. The Committee is of the considered view that this trend is indicative of seriousshortcomings in formulating the Budget Estimates and ineffective monitoring of utilisation of thebudgeted funds for implementing schemes. The Committee, therefore, recommends to the Ministryto take appropriate corrective measures to arrest this trend of inappropriate projection of fundrequirements in formulating budget estimates for schemes, which are left unutilised owing to lackof approvals, non-receipt of proposals etc. The Committee would advise the Ministry to proposebudget allocations for schemes only after obtaining all necessary clearances so that the scarceresources do not remain locked up and surrendered later. (Para 2.21)

The Committee observes from Table No.4 that the Ministry incurred expenditure of `̀̀̀̀ 38.83crore of the non-plan funds in the second quarter of the Financial Year 2015-16 and has thus breachedthe ceiling of 33% as stipulated by the Ministry of Finance. The Committee would expect the Ministryto show greater financial discipline and responsibility by evenly laying out expenditure in future.

(Para 2.22)

Pending Utilisation Certificates

The Committee is concerned to note that the number of the pending UCs and the amountinvolved therein is still very high despite the efforts made by the Ministry. It is also a matter ofgreat concern that the pending UCs date as far back as 2004-05 which points to the fact that thesteps taken by the Ministry so far have not yielded the desired results. The Committee observesthat the time lag in submission of UCs delays release of funds to the implementing agencies andthus adversely affects quality of spending. It is, therefore, imperative on the part of the Ministry to

38

have a relook at the system of monitoring of the progress of utilization of the funds at the level ofimplementing agencies and come out with a multi-pronged strategy for liquidation of pending UCsso as to ensure that execution of projects is not delayed due to pending UCs. (Para 2.24)

Updation of Central Registers of Indian Medicine and Homoeopathy

The Committee has been impressing upon the Ministry the need for timely updation ofCentral Registers of Indian Medicine and Homoeopathy. The Committee notes that the Ministryhas undertaken the work of digitization of the Central Registers. The Committee observes that theupdation of both Central Registers of the Indian Medicine and Homoeopathy is of vital importancefor HR planning and forecasting. The Committee, therefore, recommends to expedite the workrelating to updation and digitization of both the Central Registers. The Committee also desires tobe apprised of the progress made in this regard. (Para 3.5)

National Institutes

National Institute of Ayurveda (NIA), Jaipur

The Committee has been reviewing the vacancy position at NIA, Jaipur and urging theMinistry to fill them up within a short span of time. The Committee is, therefore, deeply concernedto note that out of 95 Group ‘A’ posts, as many as 23 are vacant. The Committee observes that sucha large number of vacancies in Group ‘A’ posts will certainly lead to compromise in its mandatedactivities and affect the quality of teaching and research at NIA. The Committee would, therefore,reiterate its recommendation made in its 84th Report that the Ministry may explore the possibilityof appropriately revising the methods and conditions of recruitment of senior faculty withoutcompromising the requisite standards. (Para 4.4)

National Institute of Homoeopathy (NIH), Kolkata

Taking into account that a number of vacancies in teaching cadre had been persisting sincelong, the Committee in its 84th Report on Demand for Grants (2015-16) of the Ministry hadrecommended to amend the Rules relating to recruitment, service conditions and quantum ofemoluments of Group ‘A’ posts at NIH so that it would attract talent towards this profession andfacilitate filling of posts. Almost a year has elapsed since then, but the Recruitment Rules (RRs)are still under finalization. The Committee observes that NIH not only imparts education inHomoeopathy, but also serves as a model for other institutes/colleges across the country and thereforefilling of vacant faculty posts at the earliest is of vital importance. The Committee, therefore,recommends that the finalization of amendments to RRs may be completed in a time bound manner.The Committee also desires to be apprised of the updated vacancy position of the faculty at NIH.

(Para 5.4)

The expansion of the Hospital at NIH from 100 to 250 bed has been engaging the attention ofthe Committee and has been commented upon in its various reports on Demands for Grants of theMinistry. The Committee observes that the expansion of the Hospital at NIH was targeted to becompleted during 2010-11. During the examination of Demands for Grants (2013-14), the Ministryhad informed the Committee that the original cost of `̀̀̀̀ 11.59 crore had been revised upward to`̀̀̀̀ 13.08 crore and that the project of the expansion of the Hospital Building was likely to be completedby May, 2015. The Committee is, therefore, astonished to note the submission of the Ministry that

39

“major works had been completed and the project was expected to be completed by May, 2016. TheCommittee would, therefore, like the Ministry to explain as to why the project could not be completedby May, 2015 and whether the further delay of one year has entailed any cost escalation of theProject. (Para 5.7)

The Committee notes that the research activities on Osteoarthritis, Thyroid disorders andCancer are being undertaken at NIH. The Committee observes that research projects often witnessappreciable time-lag in translating research leads and outcomes into tangible health products. TheCommittee, therefore, recommends that the Ministry should ensure that the above research projectsare taken to their logical conclusion within the shortest possible span of time and the productsgenerated out of the research projects reach our healthcare system and are used by the people.

(Para 5.9)

All India Institute of Homoeopathy (AIIH)

The Committee notes that the preliminary cost estimates for the AIIH was between`̀̀̀̀ 300-350 crore excluding the cost of the land and observes that it has been seen that the infrastructureprojects often experience time and cost overruns. The Committee would, therefore, like the Ministryto ensure that the implementation of AIIH may be monitored closely at a sufficiently higher levelin the Ministry and ensure that there is no tardiness in implementation of the Project and theresultant cost escalation. The Committee also recommends that all pre-project formalities maybe completed within a set time-frame before making budgetary provisions for the AIIH.

(Para 6.2)

Morarji Desai National Institute of Yoga (MDNIY), New Delhi

The Committee notes that the allocation of `̀̀̀̀ 12.00 crore made for MDNIY on the plan sideat the stage of BE 2015-16 was reduced to `̀̀̀̀ 1.18 crore at the RE stage. The sum of `̀̀̀̀ 12.00 crore wasearmarked for carrying out very important activities like setting up of laboratories, covering ofamphitheatre, recruitment of faculties for B.Sc. degree courses in Yoga Science etc. which havesignificant bearing on improving the teaching of Yoga. It is, therefore, a matter of anguish for theCommittee that substantial variations have occurred between the sanctioned provisions and theactual expenditure and a substantial amount of funds remained locked up due to the inefficienciesin the planning process. The Committee, therefore, recommends that the Ministry should takecredible action to overcome the deficiencies in the planning process and ensure that the blockage offunds and their subsequent surrender do not recur. (Para 7.8)

The Committee observes that among the quantifiable deliverables for 2016-17 are openingof Yoga Therapy Centres in AYUSH/ Allopathic Hospitals and preventive Healthcare units of Yoga inCGHS dispensaries. The Committee desires to be kept apprised of the achievements made vis-à-vistargets sets under these programmes. (Para 7.10)

Regulation of Naturopathy and Yoga

The Committee observes that Yoga is being practised as part of healthy lifestyle and ispopular world-wide. The therapeutic potentials of yoga in the treatment of many life-style relatedor psychosomatic disorders have been demonstrated in several studies. Similarly, Naturopathy hasgreat health promotive and restorative potential. The Committee feels that at a time when yoga

40

centres and naturopathy clinics are mushrooming, standardization of yogic practices and naturopathictreatments and their regulation are of vital importance. The Committee, therefore, desires to bekept apprised as to what was the outcome of the proposal for regulation of Yoga and Naturopathy.

(Para 8.2)

North Eastern Institute of Ayurveda and Homoeopathy (NEIAH), Shillong

The Committee is constrained to observe that the proposal for establishment of NEIAH wasaccorded approval by the Cabinet way back in May, 2008. Almost nine years have elapsed sincethen, but the full operationalization of NEIAH is yet to be realised. The inordinate delay in fulloperationalization of NEIAH has resulted in the budgeted funds remaining under-utilized andsurrendered year after year. The Committee notes that as against the total approved outlay of`̀̀̀̀ 146.51 crore for the project, the RE during the first four years of the Twelfth

Plan is only `̀̀̀̀ 49.72

crore and the amount expended is even lower at `̀̀̀̀ 29.23 crore. The Committee observes that hadthe Ministry taken appropriate remedial measures to remove deficiencies in project formulationand implementation of the Project, obtained all clearances in time and streamlined its monitoringmechanism, the full operationalisation of the project could have been realised by now. The Committee,therefore, recommends even at the risk of sounding repetitive, that corrective steps may be takenfor addressing the recurrent problem of delays in implementation of this Project. (Para 9.5)

North Eastern Institute of Folk Medicine (NEIFM), Passighat

The Committee deprecates the Ministry for failing to fully operationalise the NEIFM whichaims to revitalise, promote and harness local health traditions of the North Eastern Region of thecountry, even after revising four times the time-line for its completion. The Committee hopes thatthe Ministry would fulfil its assurance to this Parliamentary Committee and fully operationalisethe NEIFW during 2016-17. The Committee desires to be kept apprised of the date of fulloperationalisation of NEIFM. (Para 10.5)

All India Institute of Ayurveda (AIIA)

The Committee observes that the Ministry has not been able to utilise the budgetary allocationsfor AIIA like other schemes mainly due to slow progress of construction and procurement by M/sHSCC and delay in obtaining clearances from local bodies. The Committee observes that theseimpediments could have been overcome had the Ministry proactively monitored and pursued thematter with the implementing agency. The Committee expresses its strong displeasure at the tardyprogress of implementation of the Project that has led to cost escalation as well as surrender of thebudgeted funds. The Committee recommends that the Ministry should evolve a strong monitoringmechanism under which periodic/quarterly meetings should be held to keep a track on the progressof operationalisation of the Institute. The Committee also desires the Ministry to ensure that therewill be no further escalation of the project cost. (Para 11.6)

Regulation and Quality Control of Ayurvedic, Siddha, Unani and Homoeopathic (ASU&H) Drugs

The Committee observes that to enhance the acceptability of ASU&H medicines within thecountry and abroad, the quality control and standardization is of prime importance, but the regulatoryframework of certification and quality control of AYUSH remedies is very weak, which raises seriousconcerns regarding safety issues. The Committee in its Reports on Demands for Grants of the

41

Ministry of AYUSH (erstwhile Department of AYUSH) has been commenting on quality assuranceand standardization of Ayurveda, Siddha, Unani and Homoeopathic medicines and urging the Ministryto speed up strengthening and streamlining of regulatory mechanism of ASU&H drugs. TheCommittee is aware that there is a separate Chapter-IV A in the Drugs and Cosmetics Act, 1946which regulates the manufacture and sale of ASU drugs. Since the enforcement of provisions ofDrugs and Cosmetics Act and Rules made thereunder is under the purview of State Drug Licensingand Drug Control Authorities, the State Drug Regulatory Framework has a crucial role to play inensuring safety and quality of ASU & H drugs. It is in this context that the Committee views withseriousness the submission of the Secretary (AYUSH) that the State Drug Regulatory framework isvery weak and State Drug Licensing Authorities are very ill-equipped both technically andinfrastructurally, to handle the task of regulation of AYUSH medicines. The Committee also takesnote of the submission of the Secretary (AYUSH) that it is the allopathic side which does the regulationof AYUSH medicines and the AYUSH industry regulation gets neglected because the State regulatorsare more focussed on modern medicine than on AYUSH products as a result of which regulatoryneeds of standardization and quality control of ASU&H drugs get seriously impaired. The Committeealso observes that quality control and standardization of ASU&H drugs, which are mainly herbal/herbo-mineral preparations, is very complex and different from synthetic molecules of the allopathicsystem which are produced under controlled laboratory conditions. Taking all these facts into account,the Committee recommends that the Government should move quickly towards setting up a separateregulator for AYUSH industry and apprise the Committee of the time-frame within which a separateregulator for AYUSH industry would be set up. The Committee also desires to be apprised of therecommendation of the AYUSH Task Force set up by Government under Chairmanship of Prof. H.R. Nagendra on the issue of regulator for the AYUSH industry. (Para 12.13)

The Committee also recommends that the Ministry should avoid the prolonged andprocrastinated discussion with the concerned entities on the issue of creating a separate regulatorystructure for the AYUSH industry and iron out all inter-ministerial issues within a span of threemonths from the presentation of this Report. (Para 12.14)

The Committee also observes that the quality assurance of the ASU&H drugs cannot beachieved by creating a separate regulatory structure for the AYUSH industry alone. A host of otherissues like creation of new drug testing laboratories and equipping them with the state-of-the-arttechnology to enable them to carry out sophisticated analysis of AYUSH drugs, upgradation of theexisting Central Drug Testing Laboratories, implementation of an effective result-orientedpharmacovigilance programme, etc. will also have to be addressed to achieve the desired objectives.The Committee, therefore, recommends that a clear roadmap for creation of new drug testinglaboratories equipped with the state-of-the-art technology, capacity building of the existinglaboratories, upgradation of the existing Central Drug Laboratories and implementation of a robustpharmacovigilance programme to collect adverse drug reaction data in a systematic manner, maybe chalked out and implemented without further delay. The Committee desires to be kept apprisedof the steps taken and the progress made in this regard. (Para 12.15)

The Committee in its earlier Reports has been commenting upon the misleadingadvertisements concerning AYUSH remedies over TV and radio and in the print media and exhortingthe Ministry to take necessary remedial measures in preventing inappropriate advertisements inelectronic and print media. The oft-repeated contention of the Ministry in this regard has been that

42

due to ineffectiveness of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954,it has not been possible to take stringent action against the misleading and exaggerated claims ofefficacy of the AYUSH remedies. Subsequently, the Ministry constituted on the recommendation ofthe Committee, a Task Force for the purpose of suggesting amendments in the aforesaid Act. TheMinistry in its Action Taken Notes on the 84th Report of the Committee had inter-alia informedthat Department of Health and Family Welfare, under whose jurisdiction Task Force for suggestingamendments in the Drugs and Magic Remedies Act, 1954 was constituted, has been requested toexpedite consolidation of the amendment provisions recommended by the Task Force. The Committeenotes that there has been recurring delays in amending the Drugs and Magic Remedies (ObjectionableAdvertisements) Act, 1954 and Rules framed thereunder. Though the process of amending the saidAct and Rules has been set in motion, its logical culmination is still some distance away. TheCommittee, therefore, recommends that the Ministry should vigorously pursue the matter ofamending the said Act and Rules thereunder. The Committee also recommends that apart fromgiving sharper teeth to the Drugs and Magic Remedies Act, a provision should also be incorporatedin the relevant Rules to ban such practices and penalise offenders. (Para 12.16)

It is a matter of serious concern for the Committee to note that there is no proper definitionof what a new drug is and there are no stringent norms requiring the manufacturer to providerigorous proof of both, safety and efficacy of a new AYUSH drug and license to a new drug is givenwithout proof of efficacy and safety. The Committee, therefore, welcomes the decision of the Ministryon framing rules requiring the manufacturer to subject a new drug to clinical trials before thelicense is given to the same by the State Drug Licensing Authority. The Committee exhorts theMinistry to proactively pursue finailization and notification regarding definition of what a new drugis. The Committee desires to be kept apprised of the progress made in this regard. The Committeeobserves that there are two categories of existing drug formulations. One category has main classicalformulations. The other category has drugs which have been introduced in the market as patentand proprietary drugs over the last 20-30 years. All kinds of exaggerated claims have been made onthe labels of these patent and proprietary drugs about their efficacy in treating various diseasesincluding cancer, obesity, hypertension etc. The Committee notes that the Ministry is working onenforcing stricter definition of a new drug prospectively. But the damage has been done by all suchdrugs as have been introduced in the market in the last ten years, without rigorous proof of efficacyand safety. The Committee, therefore, recommends that it is imperative for a credible regulatoryand certification system that manufacturers of all patent and proprietary ASU&H drugs which havebeen introduced in the market in the last ten years, should be required to prove their efficacy andsafety through clinical trials over the next five years. The Committee wishes to be apprised of theconcrete action taken in this regard. (Para 12.17)

National AYUSH Mission (NAM)

The Committee observes that India has a rich heritage of AYUSH systems of medicinesand therapies and co-location of AYUSH facilities with allopathic facilities will not only providepeople options to avail treatment of their choice but also help bridge the gaps in healthcare. SinceMission means to have a performance objective, a cost objective and a time objective, the Committeewould like the Ministry to fix quantitative targets in terms of the above objectives for 2016-17and test the success of the National AYUSH Mission on the touchstone of these three objectives.The Committee desires to be apprised of the achievements made vis-à-vis targets set under theNAM for 2015-16. (Para 13.6)

43

The Committee feels that it would be difficult to step up the process of mainstreaming ofAYUSH without standardizing drugs and treatment protocols of AYUSH therapies. The Committeewould, therefore, like the Ministry to devote its attention towards nurturing AYUSH systems ofmedicines through standardization of drugs and treatment protocols. (Para 13.7)

National Medicinal Plants Board (NMPB)

The Committee notes that to update the current scenario of demand and supply of MedicinalPlants in the country, the Ministry has commissioned a fresh study under Indian Council ofForest Research and Education (ICFRE), Dehradun. The Ministry should proactively pursueconclusion of the study within a given time-frame. The Committee desires to be apprised of thefindings of ICFRE and action taken thereon by the Ministry. The Committee also wishes to beapprised of the blueprint to be prepared by FEDMAP and FRLHT for institutionalization of MPmarket. (Para 14.5)

Scheme for Grant-in-Aid to Non-Profit/Non-Governmental AYUSH Organisations/Institutions forUpgradation to Centres of Excellence

The Committee observes that for making full use of all research capacity in the field ofAYUSH in the country, activities and innovations in private and non-voluntary sector would need tobe supported financially, particularly in the wake of the fact that majority of the AYUSH institutionsare in the private sector. Since the prime objectives of the scheme for Grant-in-Aid to Non-profit/non-governmental institutions are to support AYUSH knowledge institutions engaged in clinicalresearch, inter-disciplinary research in pharmacy or drug development, bridging the gap betweenAYUSH and modern science, etc. this scheme is of vital importance from the point of view offostering collaborative and inter-disciplinary AYUSH research. The Committee, therefore, welcomesthe initiative of the Ministry towards holding deliberations with eminent experts and reputedorganisations including AIIMS for the purpose of carrying out modifications in the scheme. TheCommittee expects the Ministry to expedite finalization of the revised scheme at the beginning ofthe Financial Year 2016-17. The Committee would like to be apprised of the efficacy of the revisedscheme in ensuring prompt receipt of proposals from the stakeholders. (Para 15.8)

Research Councils

The Committee takes note of the various research projects of the Research Councils andobserves that no amount of pure research will be able to meet the needs of our health system unlessthe knowledge generated through research projects leads to efficacious health interventions andinnovations that could help realization of AYUSH potential in healthcare. The Committee would,therefore, like to be apprised about the research leads generated through research projects of thefive research Councils that have been translated into specific health products/processes.

(Para 16.20)

The Committee also recommends that the Research Councils of the Ministry of AYUSHshould be benchmarked with the best research institutions in their domain at international level sothat the Research Councils could emulate them and achieve high levels of performance. TheCommittee also recommends that there should be clearly articulated transparent criteria for appraisaland evaluation of their research projects with regard to their impact on the health system.

(Para 16.21)

MINUTES

*VIIIEIGHTH MEETING

(2015-16)

The Committee met at 2.30 P.M. on, Monday the 21st March, 2016 in Room No. 139, FirstFloor, Parliament House Annexe, New Delhi.

PRESENT MEMBERS

1. Prof. Ram Gopal Yadav — Chairman

RAJYA SABHA2. Shri Rajkumar Dhoot3. Dr. Bhushan Lal Jangde4. Shrimati B. Jayashree5. Shrimati Kahkashan Perween6. Shri Ambeth Rajan7. Shri Jairam Ramesh

LOK SABHA8. Dr. Subhash Ramarao Bhamre9. Shrimati Ranjanaben Bhatt

10. Shri Devendra alias Bhole Singh11. Dr. (Smt.) Heena Vijay Gavit12. Shri Arjunlal Meena13. Shri J. Jayasingh Thiyagaraj Natterjee14. Shri C. R. Patil15. Shri M. K. Raghavan16. Dr. Manoj Rajoria17. Dr. Shrikant Eknath Shinde18. Shri Kanwar Singh Tanwar19. Shrimati Rita Tarai

SECRETARIATShri Pradeep Chaturvedi, DirectorShri Dinesh Singh, Joint DirectorShri Rajesh Kumar Sharma, Assistant DirectorShri Pratap Shenoy, Committee Officer

*Minutes of 1st to VIIth meeting relate to other matters.

47

48

WITNESSES

Representatives from Ministry of AYUSH

l. Shri Ajit M. Sharan, Secretary2. Shrimati Vijaya Srivastava, Additional Secretary & Financial Advisor

3. Shri Jitendra Sharma, Joint Secretary,4. Shri A.K.Ganeriwala, Joint Secretary5. Shri Anurag Srivastava, Joint Secretary

6. Shrimati Bharti Das, Chief Controller of Accounts7. Dr. Rais-ur-Rehman, Adviser (Unani)

8. Dr. Monaj Nesari, Adviser( (Ayurved)9. Dr. D.C.Kotoch, Adviser(Ayurved)

10. Shrimati Shomita Biswas, Chief Executive Officer, National Medical Plants Board11. Dr. K.S.Dhiman, Director, Central Council for Research in Ayurvedic Sciences

12. Dr. R.K.Manchanda, Director General, Central Council for Research in Homoeopathy13. Dr. Ishrawa Nayarakere, Director General, Central Council for Research in Homoeopathy

14. Dr. R.S.Ramaswamy, Director General, Central Council for Research in Siddha15. Dr. Abhimanyu Kumar, Director, All India Institute of Ayurveda16. Dr. I.V.Basavaraddi, Director, Morarji Desai National Institute of Yoga

17. Dr. K.Shanker Rao, Director, National Institute of Ayurveda18. Dr. S.K.Nanda, Director, National Institute of Homoeopathy

19. Dr. P .K.Goswami, Director, North Eastern Institute of Ayurveda and Homoeopathy20. Dr. Otem Dai, Director, North Eastern Institute of Folk Medicine

* * *

1. Opening Remarks

2. At the outset, the Chairman welcomed Members of the Committee and briefed them about theagenda of the meeting, i.e., examination of Demands for Grants (2016-17) of the Ministry of AYUSH andDepartment of Health Research (Ministry of Health and Family Welfare) and hearing oral evidence of theSecretaries of the Ministry of AYUSH and Department of Health Research, respectively, thereon.

II. Oral Evidence of the Secretary, Ministry of AYUSH

2. The Committee then heard the Secretary, Ministry of AYUSH on the Demands for Grants (2016-17)of the Ministry. The Secretary made a power-point presentation on the Demands of Grants (2016-17) inter-alia highlighting the following points viz. (i) achievements of Ministry during the year including celebrationof International Yoga Day; (ii) 100% utilisation of Budget allocation for Ayush schemes/programmes andInternational Cooperation; (iii) Key Functional Areas; (iv) details of expenditure during the first 4 years ofthe Twelfth Plan including, BE,RE and Actual Expediture; (v) Steps taken for Optimum Utilization of Budget;

*Relates to other matter.

49

(vi) Comparative Statement showing Targets fixed Achievements made during the years 2014-15 and2015-16; (vii) Liquidation of Utility Certificates (UCs); (viii) Status of Utilization of fund in North-East,Scheduled Castes Sub-Plan andTribal Sub-Plan in 2015-16; (ix) Plan allocation for 2016-17; (x) NationalAYUSH Mission (NAM) and its progress; (xi) A YUSH Educational Institutions; (xii) Quality Control of ASU& H Drugs; (xiii) National Institutes like (a) National Institute of Ayurveda (NIA), Jaipur, (b) NationalInstitute of Homoeopathy (NIH), Kolkata, (c) National Institute of Unani Medicine (NIUM), Bangalore, (d)National Institute of Siddha, Chennai, (e) National Institute of Naturopathy, Pune; (f) Rashtriya AyurvedaVidyapeeth, New Delhi; (g) Morarji Desai National Institute of Yoga, New Delhi, (h) Institute of PostGraduate Teaching and Research in Ayurveda, Jamnagar; (xiv) progress of All India Institute of Ayurveda,New Delhi and North Eastern Institute of Folk Medicine, Pasighat (NEIFM) which are likely to be fullyoperational by August, 2016; (xv) Research Councils and achievements of research activities; (xvi)Achievements of National Medicinal Plants Board; (xvii) Achievements under information, education andcommunication in resepct of AYUSH Drugs Quality Control, etc.

3. Thereafter, Members raised a number of issues like the need to frame guidelines for activities ofAYUSH and give suggestions to State Governments for setting up of AYUSH facilities; framing of rules forpreventing misleading advertisements of the AYUSH products; clinical trials of AYUSH drugs and vetting bylicencing authority of products being manufactured by companies; efficacy of cancer treatment in Ayurvedasystem; need for credible regulatory and certification system in Ayurveda, etc.

4. The Secretary, Ministry of AYUSH replied to some of the queries raised by the Members. He wasthen requested by the Chairman to furnish detailed written replies to the queries which unanswered orallywithin a week.

III * * *

5. * * *

6. * * *

7. A verbatim record of the proceedings of the meeting was kept.

8. The Committee then adjourned at 5.20 P.M.

*Relate to other matters.

50

*XIELEVENTH MEETING

The Committee met at 2.30 P.M. on, Thursday, the 28th April, 2016 in Room No. 63, FirstFloor, Parliament House, New Delhi.

PRESENT MEMBERS

1. Shri Jairam Ramesh — In the Chair

RAJYA SABHA2. Shri Rajkumar Dhoot

3. Dr. Bhushan Lal Jangde

4. Shrimati Kahkashan Perween

5. Shri Ambeth Rajan

LOK SABHA6. Shri Thangso Baite

7. Shrimati Ranjanaben Bhatt8. Dr. (Smt.) Heena Vijay Gavit

9. Shri Arjunlal Meena

10. Shri Chirag Paswan

11. Shri R. K. Singh

12. Shri Kanwar Singh Tanwar

13. Shrimati Rita Tarai

SECRETARIATShri Anil Kumar Gandhi, DirectorShri Dinesh Singh, Joint DirectorShri Rajesh Kumar Sharma, Assistant DirectorShri Pratap Shenoy, Committee Officer

I. Opening Remarks

2. In the absence of Chairman, the Committee elected Shri Jairam Ramesh to preside over the meeting.He apprised Members of the agenda of the meeting, i.e., to consider and adopt draft 95th Report of theCommittee on Demands for Grants (2016-17) of Ministry of AYUSH.

* Minutes of IXth to Xth meeting relate to other matters.

50

51

II. Consideration and Adoption of draft 95th Report of the Committee

3. The Committee then considered and discussed the draft 95th Report of the Committee on Demandsfor Grants (2016-17) of the Ministry of AYUSH. After some discussions, the Committee adopted the saidReport. The Committee, thereafter, decided that the Report may be presented to the Rajya Sabha and laid onthe Table of the Lok Sabha on Friday, the 29th April, 2016. The Committee authorized the Chairman of theCommittee, and in his absence Shri Jairam Ramesh and in their absence, Shri Ambeth Rajan to present theReport in Rajya Sabha, and Shri Thangso Baite and in his absence, Dr. (Smt.) Heena Vijay Gavit to lay theReport on the Table of the Lok Sabha.

8. The Committee then adjourned at 3.30 P.M.

ANNEXURES

ANNEXURE-I

TWELFTH PLAN TARGET AND ACHIEVEMENT (FINANCIAL)

(` In Crore)

Sl. Schemes/ Programmes 12th Plan 12th Plan 12th Plan 12th Plan No. Outlay BE from RE from Actual from

2012-13 to 2012-13 to 2012-13 to2016-17 2015-16 2015-16 (upto

29.2.2016)

1 2 3 4 5 6

A CENTRAL SECTOR SCHEMES

1 System Strengthening 817.00 667.09 368.02 316.24

(a) Strengthening of Department of AYUSH 170.00 124.59 105.69 93.14

1 Secretariat - Department of AYUSH 124.32 87.39 71.68 63.76

2 Pharmacopoeia Committees of ASU and 45.68 14.70 5.19 2.85strenghtening of PharmacopoeiaCommision of Indian Medicine (PCIM)

3 Aqusition of Office Building 22.50 28.82 26.53

(b) Statutory Institutions 4.00 5.98 4.13 3.07

1 Grant to Central Council of Indian 3.08 5.00 3.00 2.09Medicine, New Delhi

2 Grant to Central Council of Homoeopathy, 0.92 0.98 1.13 0.98New Delhi

(c) Hospital & Dispensaries 425.00 353.27 166.41 144.20

1 All India Institute of Ayurveda(AIIA), 218.50 222.22 106.11 98.42New Delhi

2 AYUSH expansion in CGHS 6.50 6.80 4.80 4.17

3 All India Institute of Yoga 50.00 12.80 0.00 0.00

4 All India Institute of Homeopathy 50.00 47.35 50.35 37.75

5 All India Institute of Unani Medicine 100.00 45.10 0.20 0.20

6 Yoga Training for Police Personnel 19.00 4.95 3.66

(d) Strengthening of Pharmacopeial 110.00 55.25 12.97 9.83Laboratories

55

56

1 Pharmacopoeial Laboratory of Indian 8.79 8.00 5.56 3.38Medicine, Ghaziabad

2 Homoeopathic Pharmacopoeia Laboratory, 5.16 5.35 4.33 3.37Ghaziabad

3 Public Sector Undertaking (IMPCL, 46.05 38.00 3.08 3.08Mohan, UP)

4 Homoeopathic Medicines Pharmaceutical 50.00 3.90 0.00 0.00Co. Ltd.


Information, Education and Communication 80.00 99.00 70.75 60.07

(f) AYUSH and Public Health 28.00 29.00 8.07 5.93

2 Educational Institutions 1418.00 954.40 567.66 478.95

1 Grant for Instt. Post Grad. Teaching & 51.53 43.35 24.59 20.91Research, Jamnagar

2 Grant to National Institute of Ayurveda, 146.65 142.15 93.80 87.07Jaipur

3 Grant to Rashtriya Ayurveda Vidyapeeth 42.10 40.10 20.30 13.60

4 Grant to National Institute of Siddha, 126.10 137.50 84.90 79.21Tamil Nadu

5 Grant to National Institute of 182.10 153.45 104.64 97.15Homoeopathy, Kolkata

6 Grant to National Institute of Unani 106.60 95.80 78.00 75.76Medicine, Bengaluru

7 Morarji Desai National Institute of Yoga 65.55 54.50 26.27 20.11

8 Grant to National Institute of Naturopathy, 30.46 34.56 26.57 17.14Pune

9 North Eastern Institute of Ayurveda and 146.51 97.54 49.72 29.23Homoeopathy, Shillong

10 North Eastern Institute of AYUSH/Folk 72.90 51.40 24.37 16.02Medicine, Passighat

11 Assistance to accredited AYUSH Centres 97.50 89.00 34.50 22.75of Excellence in non-governmental/private sector engaged in AYUSHeducation/ drug development & research/clinical research/folk medicine etc.

1 2 3 4 5 6

57

12 National Institute of Medicinal Plants 100.00 2.05 0.00 0.00

13 National Institute of Sowa Rigpa 50.00 11.50 0.00 0.00

14 Indian Institute of AYUSH Pharmaceutical 50.00 0.90 0.00 0.00Sciences

15 National Institute of Geriatics 50.00 0.20 0.00 0.00

16 National Institute of Metabolic and 50.00 0.20 0.00 0.00Lifestyle Diseases

17 National Institute of Drug and Tobacco 50.00 0.20 0.00 0.00

De-addiction

3 Research and Development including 2124.55 1491.06 991.78 939.09Medicinal Plants

RESEARCH COUNCILS 1242.55 1147.06 751.82 722.45

1 Grant to Central Council for Research in 406.87 363.20 285.56 281.56Ayurvedic Sciences

2 Grant to Central Council for Research in 300.00 312.68 188.82 192.49Unani Medicine

3 Grant to Central Council for Research 90.00 82.50 25.38 19.13in Yoga and Naturopathy

4 Grant to Central Council for Research in 244.18 279.58 201.86 187.07Homoeopathy

5 Grant for Central Councils for Research 110.60 67.50 35.32 32.75in Siddha

6 Extra Mural Research Projects through . 23.76 26.00 11.60 7.95Research Institutes etc

7 TKDL and ISM&H Intellectual Property 7.50 6.20 0.00 0.00Rights

8 Survey on usage and acceptability of 9.64 7.20 3.28 1.50AYUSH

9 Central Council for Research in Sowa-Rigpa 50.00 2.20 0.00 0.00

National Medicinal Plant Board 882.00 344.00 239.96 216.64

National Medicinal Plant Board 882.00 344.00 239.96 216.64

4 HRD (Training Programme/Fellowship/ 110.00 21.10 8.45 5.08Exposure visit/ Upgradation of skills etc.)

1 2 3 4 5 6

58

1 Re-orientation Training Programme of 60.00 17.00 8.45 5.08AYUSH Personnel/ Continuing MedicalEducation (ROTP/CME)

2 National Commission for Human Resources 50.00 4.10 0.00 0.00in AYUSH

5 Cataloguing, Digitization etc. of 2.50 4.55 0.45 0.33 Manuscripts and Development ofAYUSH IT Tools, Applications andNetworks

Scheme for Acquisition, Cataloging,Digitisation and Publication of TextBooks & Manuscripts 1.25 2.75 0.45 0.33

Development of AYUSH IT Tools,Applications and Networks 1.25 1.80 0.00 0.00

6 International Co-operation 40.00 30.00 19.00 13.17

1 International Exchange Programme/ 40.00 30.00 19.00 13.17Seminar workshop on AYUSH

2 Promotion of International Cooperation 11.00 0.00 0.00

7 Development of AYUSH Industry 128.00 92.53 26.90 23.49

1 Development of common facilities for 121.75 88.53 24.55 21.44AYUSH industry clusters

2 Incentive to Industry - Participation in 6.25 4.00 2.35 2.05fairs/Conducting market survey

8 Funding of NGOs engaged in local Health 0.95 3.95 1.86 1.39traditions/midwifery practices etc. underAYUSH

9 Pharmacovigilance initiative for ASU drugs 15.00 5.35 0.00 0.00

10 National AYUSH Library and Archives 25.00 4.00 0.00 0.00

11 Central Drug Controller for AYUSH 102.00 12.50 0.00 0.00

TOTAL: A 4783.00 3286.53 1984.12 1777.74

B CENTRALLY SPONSORED SCHEMES

1 Promotion of AYUSH 4439.00 953.57 228.79 73.68

(a) Development of Institutions 450.00 155.00 15.00 0.00

1 2 3 4 5 6

59

(b) Hospitals & Dispensaries (under NRHM 3747.00 760.00 211.79 73.03including AYUSH flexi-pool)

(c) Drugs Quality Control 80.00 26.00 2.00 0.65

(d) Public Private Partnership for setting 12.00 1.07 0.00 0.00up of specialty clinics/IPDs.

(e) AYUSH Gram 50.00 5.70 0.00 0.00

(f) National AYUSH Health Program 100.00 5.80 0.00 0.00

2 National Mission on Medicinal Plants 822.00 205.00 166.31 139.20

New Scheme 729.90 407.56 372.31

National Mission on AYUSH (including 11.90 9.90 9.90Mission on Medicinal Plants)

National AYUSH Mission 718.00 397.66 362.41

TOTAL : B 5261.00 1888.47 802.66 585.19

GRAND TOTAL : (A+B) 10044.00 5175.00 2786.78 2362.93

1 2 3 4 5 6

6060

ANNEXURES-I

ALLOCATION/EXPENDITURE FOR 2014-15PLAN

(` In Lakhs)

Sl. Schemes/Programmes BE RE A E Excess(+)/ Reason for variationNo. 2014-15 2014-15 2014-15 Savings(-)

1 2 3 4 5 6 7


1 System Strengthening 16270.00 5133.00 5950.00 -11220.00 –

(a) Strengthening of Department of AYUSH 3550.00 2582.00 2544.00 -1006.00 –

1 Secretariat - Department of AYUSH 2200.00 1400.00 1446.00 -754.0 Saving was due to non-filling up of vacant postsand non-finalization of contract for contractualemployees

2 Pharmacopoeia Committees of ASU and 250.00 100.00 16.00 -234.00 Savings due to non-filling up of vacant posts andstrenghtening of Pharmacopoeia Commision requirement of less funds towards domesticof Indian Medicine (PCIM) travel and other establishment expenses.

3 Aqusition of Office Building 1100.00 1082.00 1082.00 -18.00 Minor variation. Funds released to NBCC basedon actual demand.

(b) Statutory Institutions 120.00 64.00 63.00 -57.00

1 Grant to Central Council of Indian Medicine, 100.00 50.00 49.00 -51.00 savings was due to non-filling up of vacant postsNew Delhi and economy measures.

2 Grant to Central Council of Homoeopathy 20.00 14.00 14.00 -6.00 In the RE the provision for funds was made toNew Delhi `14.00 lakhs and ̀ 14.00 lakhs were released

during the financial year and there was no saving.

(c) Hospital and Dispensaries 9250.00 550.00 536.00 -8714.00

1 All India Institute of Ayurveda (AIIA), New Delhi 6500.00 400.00 400.00 -6100.00 saving was due to non-operationalisation of theInstitute owing to slow progress of constructionwork

61

2 AYUSH expansion in CGHS 150.00 100.00 136.00 -14.00 Minor variation w.r.t RE.

3 All India Institute of Yoga 50.00 0.00 0.00 -50.00 Yet to be approved.

4 All India Institute of Homoeopathy 50.00 0.00 0.00 -50.00 Due to delay in identification of land.

5 All India Institute of Unani Medicine 2500.00 50.00 0.00 -2500.00 This is a new scheme yet to be approved. Savingwas due to delay in appointment of consultantsfor preparation for Detailed project Report (DPR)


1 Pharmacopoeial laboratory of Indian Medicine, 140.00 80.00 77.00 -63.00 Due to non-receipt of demand from CPWD.Ghaziabad

2 Homoeopathic Pharmacopoeia laboratory. 100.00 100.00 100.00 0.00 No variation.Ghaziabad

3 Public Sector Undertaking (IMPCI, Mohan, UP) 700.00 0.00 0.00 -700.00 0 Due to unspent balance of previous year.

4 Homoeopathic Medicines Pharmaceutical Co. Ltd. 160.00 0.00 0.00 -160.00 Due to non-approval of the Scheme.

(e) Information, Education and Communication 1750.00 1700.00 1671.00 -79.00

Information education and Communication 1750.00 1700.00 1671.00 -79.00 Minor variation w.r.t RE due to less demand.

(f) AYUSH and Public Health 500.00 57.00 59.00 -441.00 Savings was due to receipt of less proposals.

2 Educational Institutions 18890.00 10395.00 9851.00 -9039.00

1 Grant for Instt. Post Grad. Teaching & Reasearch, 600.00 500.00 385.00 -215.00 Savings was due to non-receipt of approval forJamnagar Capatil Assets.

2 Grant to National Institute of Aurveda, Jaipur 2400.00 1900.00 1780.00 -620.00 Savings was due to non-receipt of adequateproposals.

3 Grant to Rashtriya Aurveda Vidyapeeth 650.00 400.00 157.00 -493.00 Savings was due to delay in evoulation andapproval of continuation of Guru SishyaParampara Scheme.

4 Gram to National institute of Siddha, Tamil Nadu 2800.00 2300.00 2300.00 -500. 00 ` 5 Cr was projected in 2014-15 in anticipation ofobtaining NOC from the Archeaological Survey ofIndia for OPD/IPD construction work during theyear 2014-15. But the same did not receive in timehence the savings.

62

5 Grant to National Institute of Homoeopathy, 3000.00 2500.00 2500.00 . -500.00 Saving was due to receipt of less proposals.Kolkata

6 Grant to National Institute of Unani Medicine, 1740.00 1600.00 1600.00 -140.00 Savings was due to receipt of less proposals.Bangalore

7 Morarji Desai National Institute of Yoga 900.00 35.00 16.00 -884.00 Savings was due to receipt of less number ofeligible students for scholorship anddiscontinuation of some schemes and differmentof expenses.

8 Grant to National Institute of Naturopathy, Pune 900.00 300.00 280.00 -620.00 Saving was due to receipt of less proposals andnon-finalization of land allotment.

9 North Eastem Institute of Ayurveda & 2400.00 150.00 123.00 -2277.00 Savings was due to (i) The construction ofHomoeopathy, Shillong buildings which was expected to be handed over

oould not be made by HSCC. Hence saving (ii)Sanctioned posts could not be filled up.

10 North Eastern Institute of AYUSH/Folk 1350.00 140.00 140.00 -1210.00 Savings due to unspent balance of the previousMedicine, Passighat year. RE provision has been fully ulilised.

11 Assistance to accredited AYUSH Centres of 2000.00 570.00 570.00 -1430.00 saving was due to non-receipt of viable proposalsExcellence in non-governmental/private and pending utilization certificate.sector engaged in AYUSH education/drugdevelopment & research/clinical research/folk medicine etc.

12 Naiional Institute of Medicinal Plants 100.00 0.00 0.00 -100.00 Savings was due to non-approval of the Scheme.

13 Natlonal Institute of Sowa Rigpa 10.00 0.00 0.00 -10.00 Due to non-approval of the Scheme.

14 Indian Institute of AYUSH Pharmaceutical Sciences 10.00 0.00 0.00 -10.00 Due to non-approval of the Scheme.

15 National Institute of Geriatics 10.00 0.00 0.00 -10.00 Due to non-approval of the Scheme.

16 National Institute of Metabolic and Lifestyle 10.00 0.00 0.00 -10.00 Due to non-approval of the Scheme.Diseases

1 2 3 4 5 6 7

63

17 National Institute of Drug and Tobacco 10.00 0.00 0.00 -10.00 Due to non-approval of the Scheme.De-addiction

3 Research & Development including Medicinal 29420.00 18347.00 18897.00 ·10523.00Plants

RESEARCH COUNCILS 22420.00 11947.00 12567.00 -9853.00

1 Grant to Central Council for Research in 6800.00 5700.00 5706.00 -1094.00 Savings was due to non-receipt of adequateAyurvedic Sciences proposals.

2 Grant to Central Council for Research in 6100.00 2517.00 3158.00 -2942.00 Saving was due to non-filling of vacant posts,Unani Medicine non-receipt of approval for construction of

building in Silcher and receipt of less proposals.

3 Grant to Central Council for Research in 1370.00 400.00 383.00 -987.00 Saving was due to receipt of less proposals andYoga & Naturopathy non-finalization of land allotment of 2nd phase

construction work of CRI in Haryana andKarnataka.

4 Grant to Central Council for Research in 5800.00 3000.00 2925.00 -2875.00 Saving was due to non-filling up of vacant postsHomoeopathy and receipt of less proposals.

5 Grant for Central Councils for Research in 1500.00 200.00 200.00 -1300.00 Saving was due to non-receipt of approval forSiddha construction of building/laboratories and receipt

of less proposals.

6 Extra Mural Research Projects through 400.00 110.00 179.00 -221.00 Saving was due to non-receipt of utilizationResearch Institutes etc. certificates and less receipt of viable proposals.

7 TKDL and ISM & H Interllectual Property Rights 200.00 0.00 0.00 -200.00 Savings was due to non-receipt of proposals fromCouncil for Scientific and Industerial Research(CSIR).

8 Servey on usage and acceptability of AYUSH 200.00 20.00 16.00 -184.00 No new proposal for study/evaluation wasreceived from the programme officers.

9 Central Council for Research in Sowa-Rigpa 50.00 00.0 0.00 -50.00 Due non-approval of the Scheme.

64

National Medicinal Plant Board 7000.00 6400.00 6330.00 -670.00

National Medicinal Plant Board 7000.00 6400.00 6330.00 -670.00 Non-receipt of sufficient proposals from Statesand UCs pending

4. HRD (Training Programme/Fellowship/ 400.00 120.00 28.00 -372.00Exposure visit/Upgradation of skills etc.

1 Re-orientation Training Programme of AYUSH 400.00 120.00 28.00 -372.00 Due to non-finalization of proposals owing toPersonnel/Continuing Medical Education pending UCs.(ROTP/CME)

5. Cataloguing, Digitization etc. of Manuscripts and 50.00 18.00 17.00 -33.00 Due to non-receipt of proposal in time.Development of AYUSH -IT Tools, Applicationsand Networks.

Scheme for Acquisition, Cataloguing, Digitisation 50.00 18.00 17.00 -33.00 Proposal for releasing grant was received late.and Publication of Text Books & Manuscripts

6. International Co-operation 800.00 300.00 165.00 -635.00

1. International Exchange Programme/Seminar 800.00 300.00 165.00 -635.00 Non-reciept of acceptable proposals from variousworkshop on AYUSH stake holders and economy measures.

7. Development of AYUSH Industry 2450.00 250.00 150.00 -2300.00

1. Development of common facilities for AYUSH 2400.00 150.00 73.00 -2327.00 Saving was due to receipt of less proposals andindustry clusters non-receipt of Utilization Certificates.

2. Incentive to Industry - Participation in fairs/ 50.00 100.00 77.00 27.00 Savings due to less receipt of proposals.Conducting market survey

8. Funding of NGOs engaged in local traditions/ 100.00 63.00 49.00 -51.00 saving was due to slow pace of expenditure ofmidwifery practices etc. under AYUSH ongoing project and also pending Utilization

Certificates.

9. Pharmacovigilance Intiative for ASU drugs 200.00 0.00 0.00 -200.00 Due to non-approval of the Scheme.

1 2 3 4 5 6 7

65

10. National AYUSH Library and Archives 40.00 0.00 0.00 -40.00 Due to non-approval of the Scheme.

11. Central Drug Controller for AYUSH 300.00 0.00 0.00 -300.00 Due to non-approval of the Scheme.

TOTAL : A 68920.00 34626.00 34207.00 -34713.00


1. National Mission on AYUSH 29800.00 10.00 10.00 -29790.00

a) Development of Institutions 5000.00 0.00 -5000.00 The Scheme were under consideration for mergerb) Hospitals & Dispensaries (under NRHM 24000.00 10.00 10.00 -23990.00 with National AYUSH Mission. Finally, the Schemes

including AYUSH flexi-pool) have been merged with the newly re-structuredc) Drugs Quality Control 800.00 0.00 -800.00 Flagship scheme namely National AYUSH

Mission (NAM) w.e.f. 29.9.2014. Therefore, no.expenditure was incurred under individualscheme during 2014-15.

2. National Mission on Medicinal Plants 7000.00 4400.00 4567.00 -2433.00 Non-receipt of sufficient proposals from States1. National Mission on AYUSH (including 1180.00 990.00 990.00 -190.00 pending UCs. Further the Scheme has been

mission on medicinal Plants) merged with National AYUSH Mission w.e.f.29.9.2014

National AYUSH Mission 0.00 6652.00 5539.00 -113.00 The restructured CSS of NAM was launched from29.09.2014 and available funds at RE stage (exceptthe funds for UT without legislature) wereutilized.

TOTAL : B 37980.00 12052.00 12106.00 -32526.00GRAND TOTAL : (A+B) 106900.00 46678.00 46313.00 -67239.00

66ANNEXURE-II

ALLOCATION/EXPENDITURE FOR 2015-16PLAN

(` in lakhs)

Sl. Schemes/Programmes BE RE AE Excess(+)/ Reason for variationNo. 2015-16 2015-16 29.02.16 Savings(-)

1 2 3 4 5 6 7


1 System Strengthening 16500.00 11791.00 9364.00 -7136.00

(a) Strengthening of Department of AYUSH 3720.00 1900.00 1697.00 -2023.00

1 Secretariat- Department of AYUSH 2200.00 1700.00 1566.00 -634.00 Savings was due to non-filling up of vacantposts.

2 Pharmacopoeia Committees of ASU and 370.00 200.00 131.00 -239.00 Savings was due to non-filling up of vacantstrenghtening of Pharmacopoeia Commision posts.of Indian Medicine (PCIM)

3 Aquisition of Office Building 1150.00 0.00 0.00 ·1150.00 As per the direction of Ministry of Financepayment to NBCC towards acquiring officebuilding has been discontinued.

(b) Statutory institutions 145.00 155.00 155.00 10.00 -

1 Grant to Central Council of Indian 125.00 100.00 100.00 -25.00 Marginal Saving. The balance amount w.r.t RE willMedicine, New Delhi be released during March

2 Grant to Central Council of Homoeopathy, 20.00 55.00 55.00 35.00New Delhi

(c) Hospital & Dispensaries 9435.00 5879.00 4402.00 -5033.00

1 All India Institute of Ayurveda(AIIA), 2500.00 249.00 58.00 -2442.00 Savings due to i) slow trend of construction andNew Delhi procurement by M/S HSCC. ii) Non-filling up of

vacant posts and iii) delay in procurement ofvarious items. Provision provided in RE will beutilised in March.

66

67

2 AYUSH expansion in CGHS 100.00 100.00 74.00 -26.00 The remaining provision available w.r.t. RE will beutilized in March.

3 All lndia Institute of Yoga 10.00 0.00 0.00 -10.00 Savings due to non-approval of the Scheme

4 An India Institute of Homoeopathy 3825.00 5035.00 3775.00 -50.00 The provision has been increased in RE ( `12.10cr) towards payment of land cost.The balance available w.r.t. provision in RE will beutilized in March.

5 All India Institute of Unani Medicine 1500.00 0.00 0.00 -1500.00 Savings due to non-approval of the Scheme

6 Yega Training for Police Personnel 1500.00 495.00 495.00 -1005.00 Savings due to late implementation of the schemein the later part of the financial year.The RE allocation has already been utilized.


1 Pharmacopoeial Laboratory of Indian Medicine, 170.00 149.00 64.00 -106.00 Non completion of Guest House Non-receipt ofGhaziabad the Approval for renovation of Guard Room and

shed in Herb Garden.

2 Homoeopathic Pharmacopoeia Laboratory, 120.00 100.00 41.00 -79.00 Marginal savings. Remaing amount w.r.t. RE willGhaziabad be spent in March.

3 Public Sector Undertaking (IMPCL, Mohan, U.P.) 500.00 308.00 308.00 -192.00 Due to unspent balance of the previous year.

4 Homoeopathic Medicines Pharmaceuitical 10.00 0.00 0.00 -10.00 Non approval of the schemeCo. Ltd.


Information, Education and Communication 2000.00 3000.00 2403.00 403.00 Allocation was increased under RE. The balanceamount will be utilized in March.

(f) AYUSH and Public Health 400.00 300.00 294.00 -106.00 Due to less receipt of viable proposals.

2 Educational Institutions 200.00 14527.00 11803.00 -8197.00

1 Grant for Instt. Post Grad. Teaching & 780.00 673.00 673.00 -107.00 Savings due to reduction of funds at RE stage.Research, Jamnagar The provision with w.r.t. RE has been utilized

fully.

68

2 Grant to National Institute of Ayurveda, Jaipur 2400.00 1888.00 1821.00 -579.00 Savings due to funds reduction in RE. Themarginal balance amount available w.r.t, to RE willbe fumy utilized in March.

3 Grant to Rashtriya Ayurveda Vidyapeeth 1200.00 800.00 565.00 -635.00 Due to non-receeipt of adequate proposals.However. the balance amount available w.r.t. REwill be fully utilized by March.

4 Grant to National Institute of Siddha, Tamil Nadu 3050.00 2600.00 2031.00- 1019.00 Savings due to non filling up of post lessrequirment of funds towards LTC, LeaveEncashment CEA, Medical refmbursement.Advances etc., unspent balance for the year2014-15 etc.

5 Grant to National Institute of Homoeopathy, 3400.00 3200.00 2601.00 -799.00 Savings due to reduction of allocation at REKolkata stage. The balance funds available will be fully

utilized in March.

6 Grant to National Institute of Unani Medicine 2300.00 2100.00 2100.00 -200.00 Savings is due to non creation of posts forBangalore starting of six new PG departments at this

institute.

7 Morarji Desai National Institute of Yoga 1200.00 350.00 118.00 -1082.00 Savings due to i) Unspent Balance of theprevious year. ii) Late recruitment of Facultyfor B.Sc (Yoga Sciences). iii) Slow pace ofrenovation of Laboratory.

8 Grant to National Institute of Naturopathy, Pune 500.00 1266.00 490.00 -10.00 Additional fund allocated under RE for acqusitionof land. Balance funds available will be fullyutilized in March.

9 North Eastern Institute of Ayurveda and 1400.00 180.00 120.00 -1280.00 Savings due to i) Slow progress of constructionHomoeopathy, Shillong of the buildings. Non filling of vacant Posts.

10 North Eastern Institute of AYUSH/Folk 640.00 170.00 150.00 -490.00 savings due to unspent balance and slowMedicine, Passighat program of ccnstruction work.

1 2 3 4 5 6 7

69

11 Assistance to accredited AYUSH Centres of 2000.00 1300.00 1134.00 -66.00 Savings due to unspent balance of the previousExcellence in non-governmental/private sector year and receipt of less proposal. The balanceengaged in AYUSH education/drug development amount available w.r.t. to RE will be fully utilized& research/clinical research/folk medicine etc. in March.

12 National Institute of Medicinal Plants 50.00 0.00 0.00 -50.00 New scheme yet to be approved.

13 National Institute of Sowa Rigpa 1070.00 0.00 0.00 -1070.00 Savings due to non-approval of the Scheme

14 Indian Institute of AYUSH Pharmaceutical 10.00 0.00 0.00 -10.00 Savings due to non approval of the SchemeSciences

3 Research & Development Including 30000.00 28643.00 25184.00 -4816.00Medicinal Plants

RESEARCH COUNCILS 23100.00 22903.00 20105.00 -2995.00

1 Grant to Central Council for Research in 7670.00 9600.00 9200.00 1530.00 Excess funds provided for the following activities.Ayurvedic Sciences (i) NPCDCS Programme (ii) Swasthya Rakshan

Programme (iii) Development of a standardizedquestionnaire for assessment of Parkriti.(iv) Ayurved Wellness Centre at President House(v) Revised rate of purchase of land at Nerala.

2 Grant to Central Council for Research in 6600.00 4266.00 4204.00 -2396.00 savings due to unspent balance of previous year.Unani Medicine The balance amount available w.r.t. RE allocation

will be utilized fully in March.

3 Grant to Central Council for Research in 1300.00 1705.00 1080.00 -220.00 No savings. Balance funds available will be fullyYoga & Naturopathy utilized in March.

4 Grant to Central Council for Research in 5800.00 6000.00 4596.00 -1204.00 No savings. Balance funds available will be fullyHomoeopathy utilized in March.

5 Grant to Central Council for Research in 950.00 732.00 624.00 -326.00 savings due to unspent balance of previous year.Siddha The balance amount available w.r.t.

6 Extra Mural Research Projects through Research 700.00 600.00 401.00 -299.00 savings due to pending Utilization CertificateInstitutes etc. from the Grantee Institutions.

70

7 TKDL and ISM&H Intellectual Property Rights 10.00 0.00 0.00 -10.00 savings due to non-receipt of proposal.

8 Survey on usage and acceptability of AYUSH 20.00 0.00 0.00 -20.00 There in no proposal received to conduct survey/evaluation. Therefore, the fund, were surrenderedat B. E/R.E. Stage.

9 Central Council for Research in Sowa-Rigpa 50.00 0.00 0.00 -50.00 savings due to non-approval of the Scheme

National Medicinal Plant Board 6900.00 5740.00 5079.00 -1821.00

Natonal Medicinal Plant Board 6900.00 5740.00 5079.00 -1821.00 saving due to less proposal recevied.

4 HRD (Training Programme/Fellowship/ 200.00 200.00 198.00 -2.00Exposure visit/Upgradation of skills etc.)

1 Re-orientation Training Programme of AYUSH 200.00 200.00 198.00 -2.00 Balance will be used in March.Personnel/Continuing Medical Education(ROTP/CME)

5 Cataloguing, Digitization etc. of Manuscripts 80.00 0.00 0.00 -80.00and Development of AYUSH IT Tools,Applications and Networks

1 Scheme for Acquisition, Cataloging, 50.00 0.00 0.00 -50.00 Non-receipt of viable proposals.Digitisation and Publication of TextBooks & Manuscripts

2 Development of AYUSH IT Tools, Applications 30.00 0.00 0.00 -30.00 As per actual requirement.and Networks

6 International Co-operation 800.00 750.00 665.00 -135.00

1 International Exchange Programme/Seminar 800.00 750.00 665.00 -135.00 Marginal savings under Foreign Travel Expenses.workshop on AYUSH Balance amount w.r.t. allocation will be fully

utilized in March.

7 Development of AYUSH Industry 1110.00 925.00 807.00 -303.00

1 Development of common facilities for AYUSH 1060.00 875.00 759.00 -301.00 Non-receipt of viable proposals.industry clusters

1 2 3 4 5 6 7

71

2 Incentive to Industry - Participation in fairs/ 50.00 50.00 48.00 -2.00 No savings. Balance funds available will beConducting market survey fully utilized in March.

8 Funding of NGOs engaged in local Health 100.00 50.00 40.00 -60.00 Savings due to slow pace of ongoing projects andtraditions/midwifery practices etc. under also pending Ucs. The balance amount w.r.t. REAYUSH will be fully utilized in March

9 Pharmacovigilance initiative for ASU drugs 100.00 0.00 0.00 -100.00 Being a new scheme Implementation of scheme issubject to its approval.

10 National AYUSH Library and Archives 10.00 0.00 0.00 -10.00 savings due to non-approval of theScheme

11 Central Drug Controller for AYUSH 100.00 0.00 0.00 -100.00 Approval of cabinet for vertical structure required

TOTAL: A 69000.00 56886.00 48061.00 -20939.00


New Scheme

National AYUSH Mission 31800.00 33114.00 30030.00 -1770.00 Additional fund has been proposed under REwhich will be utiliized in March on receiptof approval.

TOTAL : B 31800.00 33114.00 30030.00 -1770.00

GRAND TOTAL : (A+B) 100800.00 90000.00 78091.00 -22709.00

demands for grants 2016-17 (demand no. 5) of the (ministry of …164.100.47.5 › newcommittee ›...

Documents